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Abortion is the major factor of infertility in most part of the world. The 
increasing incidence of the cases of recurrent spontaneous abortion (RSA) 
particularly of unknown etiology in Indian females warrant an in depth study so as 
to cope with this problem by understanding the cause, developing the required 
remedy and possible designing of the preventive measures. Most of the studies 
have focused on correlating the genetic, anatomical, nutritional, immunological, 
endocrinological, and infection related factors in causation of RSA despite of the 
fact of their meager contribution particularly in explaining the idiopathic RSA. 
Unexplained recurrent spontaneous abortion (URSA) is defined as 
minimum of two consecutive abortions in women desirous of a child (Meka and 
Reddy, 2006). URSA is a serious socio-economic problem affecting 5% of fertile 
couples. It is also a matter of extreme concern and remained the focus of utmost 
attention to the researchers of all times (Coulam et al (1997)). URSA without a 
history of live birth are categorized as primary URSA and those with a history of 
live birth(s) are categorized as secondary URSA. In this study we took 80% of 
secondary URSA and 20% primary URSA. Absence of congenital, inflammatory, 
traumatic, neoplastic, and degenerative or other biochemical factors in URSA led 
us to focus on epigenetic factor to understand this phenomenon. 
As we are aware that both genetic and epigenetic factors contributes RSA, 
while epigenetic factors have not been adequately explored so far and that is why 
we have chosen to explore the role of epigenetic factor of methylation ofDNA and 
its relation with the expression of other related genes involved in the etio-
pathogenesis of URSA. 
The study has been meticulously planned based on available results of 
earlier workers in this field to select the relevant parameters for the test to prove 
our hypothesis that the methylation of gene p53 is implicated in the etio-
pathogenesis of URSA. Also the study has been aimed to provide necessary basic 
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information to coin a laboratory test for the confirmation and diagnosis of the 
URSA cases and hence facilitate in the management of the cases of URSA. 
For achieving the aforesaid goal, the methylation status of gene p53 was 
assessed through Methylation specific polymerase chain reaction (MSP), degree 
ofapoptosis was assessed through TUNEL assay, while the reverse transcriptase 
polymerase chain reaction (RT-PCR) was performed for expression analysis at the 
transcript level and Immunohistochemical analysis (IHC)for expression at protein 
level which was further validated by western blotting (WB). While scanning 
electron microscopy (SEM) was performed for surface characterization. All the 
tests were performed on the decidual/endometrial tissue (DET) of both normal 
(NEP) and URSA cases. 
Attempts have been made to help for developing a screening modality to 
diagnose the cases of URSA by surface characterization of normally stored DET 
through SEM imaging. 
The statistical analysis was performed through Student-t-test and ROC 
curve analysis of the results obtained through the tests performed. 
The methodology adopted for the collection of sample in these cases were 
in accordance to the methodology as used by Kara et al, (2007) with more strict 
inclusion-exclusion criteria to obtain a reliable result. Apart from the informed 
written consent fiom each of the individuals from whom the samples has been 
taken, rest of the statutory and/or obligatory legal formalities/permissions have 
also been obtained from the concerned persons/authority. 
We have collected fresh DET samples from the subjects of 12NEP and 15 
URSA (Sprimary and 12secondary aborters) and divided the samples into two, 
first part was directly kept in an autoclaved vial, sealed and dipped the vial in 
liquid nitrogen and this snap frozen sample had been stored at -80°C for RNA 
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(RT-PCR) and protein analysis (WB). The second part of the saline washed 
collected specimen ofDET was kept in a vial containing 10% formalin stored at 
room temperature for IHC and SEM analysis. All the samples were collected from 
admitted patients of the hospitals with prior permissions from the concerned 
authorities and after obtaining a written informed consent from the individual 
subjects for conducting these tests. 
Results of the test of the aforesaid analysis were found to be statistically 
and significantly different in the cases of URSA when compared to the NEP 
confirming thereby our hypothesis that DNA methylation of the gene p53 is 
implicated in etio-pathogenesis of URSA through the process ofapoptosis. 
The aforesaid analysis also points towards the pivotal role played by 
methylation of the gene p53 in causation of URSA and hence the manipulation of 
methylation by certain agents/drugs could advantageously be used for a desired 
outcome. The level of methylation of a gene could successfully be altered as 
desired, by any methylating/demethylating agent(s) and/or drug(s), provided their 
use are devoid of causing any side effects. 
Further study could be undertaken in a direction to design a protocol to 
either terminate unwanted pregnancies or for population control. 
^^^m P a g e I iii 
8TUDT OF VARIOUS FACTORS INVOLVED 
IN RECURRENT SPONTANEOUS 
ABORTION IN FEMALES 
, , - * ' 
y^'v J! THEStS V; 
SUBUBflTED FOR THE AWARD OF TH^ ^EGR^E OF 
^ ' ^ ^ N •" \ • 
dBoctar of $i)tIos(o$i|p^ 
N I S ^ I L T F A T I M A 
Under the Supervision of 
Dr. M. Owais 
% ^ ^ 
> fi:r 
X y ' ^ Q 
INTERDISCIPLINARY BIOTECHNOLOGY UNIT 
ALIGARH MUSLIM UNIVERSITY 
ALIGARH~202002 (INDIA) 
2010 
I't^ :^y 
l b K?'^  
10^^ 
T7': 
INTERDISCIPLINARY BIOTECHNOLOGY UNIT 
ALIGARH MUSLIM UNIVERSITY, ALIGARH-202 002 (INDIA) 
Ph. 
Fax 
Email 
0091-571-2720388 
0091-571-2721776 
alg_btisamua@sanchamet.iti 
Certifitate 
Dated..Q."^:.Q?:.^.IO 
This is to certify that the thesis entitled "Study cf various factors iswohed 
in recurrent spontaneous aSortion in females' comprises the originaC worH^done by 
Miss O^fiat Tatima under my guidance ^ preceptors hip, and I find it suitaSlefor 
the award of (Ph.(D. f 
((Dr. Mohd Owais) 
Supervisor 
(Declaration 
I hereSy declare that the thesis entitled "Study of various factors involved 
in recurrent spontaneous aSortion in females" emSodies the wor^carried 
out 6y me. 
Nishat Fatima 
Research Scholar 
Int. Biotechnology Unit, 
Aligarh Muslim University, 
Aligarh-202002, India 

^cknotolebsement 
firstCy I wcmCcC Cike to Bow in reverence to tfie yiCmigfity 
far jyravidCmg rm strength during tfiis research effort & BCessed 
me with the jrresence ofmyfamiCy ancC many jfeqpCe who have 
assisted andC cooperated with me in this endeavor. 
first of aCC I wish to offer my sincere gratitude to my 
supervisor, Thr, M. Owais for his unending support, constant 
encouragement, esteemed supervision, constructive criticism, 
and stimuCating discussion during the course of my thesis work. 
J{e has Been kind enough to give me the CiBerty to approach him 
whenever needed despite his very Busy academic scheduCe. I 
have Been amazingCy fortunate to have a wonderfuCsupervisor 
whose aBsoCute invoCvement Cedto compCetion of the thesis. 
I wouCd Cike to express my sincere thanks to the 
coordinator Int. "Biotech. Vnit, Trof M. SaCeemuddin for 
providing aCCfaciCities and remaining so generous throughout 
the course of my study. 
I am sincereCy thankfuCto the other facuCty memBers of my 
department Dr. 'Rizwan 3{. Xhan, Vr. JAsaduQJah Xhan andVr. 
3{inafor their hjeCp andaBCe advices. 
I have no words to express deep sense of gratitude to aCC 
my friends. Senior's and Junior's. 
My speciaC thanks goes to T>r. Jatinder Xaur (Scientist, 
Department of Biochemistry, JAIJMS) who heCpedme at the most 
odd time of my research and aCways gave me her heCping hand 
whenever I needed 
I wouCd aCso Cike to thank Dr. Sudha Saffian (JC.O.D, 
Department of QynecoCogy and OBstetrics, Safdarjung 3<ospitaC, 
!Hey^ Delhi) ancCaCCtfie otfier staff memBer offier department for 
their kincCsupport andfieCp in sampCe coCCectioru 
I wouCcC Cike to aCso acknxywCedJge IIQC for the constant 
ftnanciaCsupjfort during my TfiT). work. 
I wouCd aCso Cike to thank aCC the participants who have 
permitted to use their santpCes for my research work. 
I find no words to express my gratitude to my parents and 
my Brothers !KaBeeB, Muaz, J^rqam and SaCman who have 
aCways made me feeC speciaC, Coved and given me the freedom to 
Be what I want. Their constant support and encouragement over 
aCCthe distance, aruCinspite of them having no idea of my work 
aCways touched my heart. I wouCdCike to thank my mother who 
managed home even inspite of Being unweCC which made it 
possiBCefor me to carry out my further studies. Last But not the 
(east, I wcniCd Cike to thank my father inparticuCar who aCways 
stood By my side Cike a piCCar in aCC the odds even in his Busy 
scheduCzs. IVithout my parents and Brothers I cant think haw I 
wouCd have managed to come so far. 
JsOsfiat fatima 
CONTENTS 
Page No. 
List of Abbreviations I-II 
List of Figures III-IV 
List of Tables V 
Chapter 1 Introduction 1-3 
Chapter 2 Review of Literature 4-40 
2.1 Early Human embryonic development 4-8 
2.1.1 Fertilization 
2.1.2 Implantation 
2.1.3 Placentation 
2.1.4 Gastrulation and organogenesis 
2.2 Recurrent Spontaneous Abortion (RSA) 8-21 
2.2.1 Maternal diseases 
2.2.2 Genetic factors 
2.2.3 Anatomical causes 
2.2.4 Environmental factors 
2.2.5 Stress 
2.2.6 Microbial infections 
2.2.7 Smoking and Alcohol 
2.2.8 Endocrinological factors 
2.2.9 Immimological factors 
2.3 Unexplained RSA 22-23 
2.4 Epigenetics 23-29 
2.4.1 DNA methylation 
2.4.2 DNMT - 1 
2.4.3 G9a Methyl Transferase: Role in implantation 
2.5 Apoptosis 30-35 
2.5.1 Tumor suppressor: p53 
2.5.2 Apoptosis: Role in pregnancy 
2.6 SEM imaging 35-36 
2.7 Receiver operative characteristic curve 36-40 
(ROC) analysis: An evaluator of test performance 
2.7.1 Sensitivity and specificity of the tests 
2.7.2 Statistical comparisons of multiple tests 
By use of ROC plots 
Chapter 3: Aim, Hypothesis and Objectives 41 
Chapter 4: Rationale of Study 42 
Chapter 5 Materials and methods 43-67 
Chapter 6 Observations and results 68-114 
Chapter 7 Discussion 115-123 
Chapters Conclusion 124-125 
Chapter 9 Bibliography 126-151 
Appendix 
ABBREVIATIONS AND SYMBOL 
A.D 
Ab 
Ag 
AUC / (A) 
BPB 
BSA 
BV 
C.I 
CHM 
D&C 
DAB 
DC 
DDW 
DEPC 
DET(S) 
DNA 
DNMTl 
dNTP 
EDTA 
EGTA 
EP 
FBS 
G.E 
G9aMT 
HP 
IFN 
Ig 
Area Difference 
Antibody 
Antigen 
Area under the Curve 
Bromophenol Blue 
Bovine Serum Albumin 
Blood vessel 
Confidence Interval 
Complete Hydatidiform Mole 
dilatation and curettage 
3,3 '-Diaminobenzidene 
Decidual cell 
Double Distilled Water 
Diethyl Pyrocarbonate 
Decidual/endometrial tissue (System) 
Deoxyribose nucleic acid 
DNA methyl transferase 1 
deoxynucleotide triphosphates 
Ethylene diamine tetra acetate 
Ethylene 
Early pregnancy 
Fetal Bovine Serum 
Glandular Epithelium 
G9a Methyl transferase 
histopathological 
Interferon 
Immunoglobulin 
Page 11 
IHC 
M 
MMLV 
MSP 
MTP 
NEP 
PAGE 
PBS 
PCR 
PUO 
PVDF 
RNA 
ROC 
RSA 
RT-PCR 
S 
S.E 
SDS 
SEM 
TE 
TNF 
TUNEL 
U 
URSA 
WB 
Immunohistochemical 
Methylated 
Moloney murine leukemia virus reverse 
Methylation specific PCR 
Medically terminated pregnancy 
Normal Early Pregnancy 
Polyacrylamide Gel Electrophoresis 
Phosphate Buffer Saline 
Polymerase Chain Reaction 
pyrexia of imknown origin 
Polyvinyl pyrolidone difluoride 
Ribonucleic acid 
Receiver operative characteristic curve 
Recurrent Spontaneous Abortion 
Reverse transcriptase PCR 
Standard Error Mean 
Standard Error 
Sodium Dodecyl Sulfate 
Scanning Electron Microscopy 
Tris EDTA 
Tumor Necrosis Factor 
dUTP-nick end labeling 
Unmethylated 
Unexplained Recurrent Spontaneous 
Abortion 
Western Blot 
Page III 
LIST OF FIGURES 
1. Early stages of human development 6 
2. Model for the interactivity between epigenetic systems. 26 
3. Model for chromatin methylation by DNMT1/G9a complex. 29 
4. Simple schematic diagram of normal cell cycle progression 32 
leading to mitosis or cell growth or apoptosis. 
5. Role of p53 in cell cycle. 33 
6. Diagram showing central position of ROC plots in test 38 
performance evaluation. 
7. A). Agarose gel image of genomic DNA isolated from DET. 70 
B). Agarose gel results of MSP analysis showing expression of 
methylated and unmethylated p53 in the DET of URSA and NEP. 
8. Error bar graph showing the score of methylated and 71 
unmethylated p53 analyzed through MSP in the DET of both 
URSA and NEP. 
9. Representative image of TUNEL assay. 74 
10. Error-bar graph representing no. of apoptotic cells in the URSA 76 
and NEP cases. 
11. Agarose Gel image showing mRNA expression assessed through 78 
RT-PCR. 
12. Error bar graph of mRNA fold change level of genes analyzed 79 
through RT-PCR. 
13.Immunohistochemical (IHC) analysis of G9a methyl transferase 83 
(G9aMT) in NEP and URSA-EP decidual/endometrial tissue 
system (DET). 
14. IHC analysis of DNA methyl transferase (DNMTl) in NEP and 85 
URSA-EP decidual/endometrial tissue system (DET). 
Page I in 
15.IHC analysis of various apoptosis related protein in NEP and 87 
URSA decidual/endometrial tissue system (20X). 
16. Error Box plot representing the IHC score of NEP and URSA 88 
DET. 
17.Immuno-blot images of WB analysis of Bax, G9aMT, DNMTl, 90 
p53 and Bcl-2 protein in NEP (N) and URSA (R) DET system. 
18. Error Bar graph showing Fold change values of URSA (R)-EP- 91 
DET and NEP (N)-DET proteins analyzed through WB. 
19. Photomicrographs of sem images of decidual/endometrial tissue 101 
(DET) of normal early pregnancy (NEP) and of unexplained 
recurrent spontaneous abortion (URSA). 
20. ROC curves of genes analyzed through RT-PCR. 103 
21. ROC curves showing the AUC (A) of the proteins analyzed 107 
through IHC. 
22. WB-ROC analysis of the protein molecules. 110 
23. ROC analysis of SEM- characteristic criteria of DET 113 
Page IIV 
LIST OF TABLES 
1. Characteristics of NK cell receptor families. 21 
2. Details of collected sample. 49 
3. Details of gene specific primer sequences for MSP-analysis. 54 
4. PCR details of primers of MSP-analysis. 54 
5. Details of gene specific primer sequences for RT-PCR. 60 
6. PCR details of primers. 61 
7. P53-MSP analysis results. 72 
8. Results of TUNEL assay. 75 
9. Results of RT-PCR analysis. 80 
lO.Results of IHC analysis of DET of NEP and URSA. 82 
11. Results of WB analysis of DET of NEP and URSA. 92 
12. Observations of SEM images of NEP and URSA-DET 94 
13. A). ROC results of RT-PCR analyzed. 105 
B). Pair-wise evaluation of genes in ROC cases. 
14. A). ROC curve analysis results of fflC. 108 
B). Pair-wise ROC curve analysis result of all the protein 
molecules analyzed through IHC. 
15. A). ROC curve analysis showing results of the proteins analyzed 111 
through WB. 
B). Pair-wise analysis of WB-ROC results. 
16. Result of SEM-ROC analysis of NEP and URSA-EP-DET. 114 
Page I V 
ir* 
Cfiapter I 
Introduction 
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The fact of 5% of fertile couples being affected worldwide by infertility 
[Coulam et al (1997)] is being commonly manifested through abortions. 
Recurrent Spontaneous Abortions (RSA) are increasingly recognized as one of 
the least understood and challenging cause of incurable infertility in India, 
particularly in the metropolitan cities. Since ever infertility is a known medico-
social entity of extreme concern, not only for a childless couple but it also 
influence the social and economic outcomes of tiie entire family in many 
regions of the world. Even today in most of the developing countries, women 
are considered to be solely responsible for barren marriages, not only this, 
infertility is also considered as a socially acceptable legal basis for divorce by 
the husbands. [Singh (1996), Leke et al., (1996) and Yeboah et al., (1992)]. 
Another fact is that, more than 50 % of couples with RSA showed 
negative results for parental karyotypes, hysterosalphingography, hysteroscopy 
and also for anti-phospholipid antibody testing, etc. Therefore, the majority 
(approximately 50 - 75 %) of couples with RSA remained undiagnosed. Facts 
regarding frequency of familial distribution, relation to parity and parental age 
are difficult to obtain reliably. In the present scenario there is an absence of any 
detectable cause for the majority of RSA cases grouped under unexplained 
RSA (URSA) having no known laboratory test for its diagnosis (Meka and 
Reddy, 2006). 
Earlier work in the field of epigenetics/molecular expressions were 
carried out on rat/mice model, shows alteration in methylation of gene p53 
implicated in causation of apoptosis and embryonic lethality (Jackson-Grusby 
et al., 2001; Pham et al., 2003), levels of DNMTl and G9aMT were found to 
be altered and related to apoptosis in cell lines (Esteve et al., 2006), while the 
ratio of Bax and Bcl-2 was found to be altered in the cases of RSA and late 
pregnancy as compared to normal early pregnancy in human (Qiao et al., 1998; 
Falco et al., 2001; Bertoja et al, 2005). 
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After thorough scrutiny of the earlier related works, we have chosen for 
our study to analyze the most probable factors, like methylation, apoptosis, and 
expression levels of Bax, Bcl-2, p53, G9aMT and DNMTl, to find out their 
role in causation of URSA. 
Methylation level of gene p53 has been assessed through Methylation 
specific polymerase chain reaction (MSP), TUNEL assay was used to find out 
the degree of apoptosis while the reverse transcriptase polymerase chain 
reaction (RT-PCR) was used for expression analysis at the transcript level and 
Immunohistochemical analysis (IHC) for expression at protein level which was 
validated by western blotting (WB). Scanning electron microscopy (SEM) was 
performed for surface characterization of normally stored tissues. All these 
tests were performed on decidual/endometrial tissue system (DETS) of both the 
cases of normal early pregnancies (NEP) and unexplained recurrent 
spontaneous abortions (URSA). The methodology of sample collection was in 
accordance to the methodology as described by Kara et al., (2007) with more 
specific inclusion-exclusion criteria. The said biopsy tissues (DETS) were 
obtained after an informed written consent fi-om every individuals, while 
observing all required ethical and legal norms. 
Expression level analyses of aforesaid genes revealed significant 
difference in both the groups with alteration in methylation status and presence 
of apoptosis. 
A successful correlation has been achieved between hypo methylation of 
gene p53, over-expression of unmethylated p53 and bax with concomitant 
decreased expression of Bcl-2, DNMTl and G9aMT with encouraging results 
of SEM imaging of tissue characterization in cases of URSA as compared to 
the cases of NEP. 
The statistical analysis of the results of aforesaid tests of 12 samples of 
NEP and 15 samples of URSA were done through Student-T- test and Receiver 
&4i^Uier ^-^yktfv^/ucUen-
Operative characteristic curve (ROC) analysis. A p-value of < 0.05 was 
considered to be statistically significant using SPSS 17.0 and Sigma Plot 10.0. 
The statistically significant positive results of aforesaid analysis could 
be utilized in designing a confirmatory laboratory test/diagnostic kit to confirm 
and/or diagnose the cases of URSA as early as the first abortion occurs. 
The aforesaid analysis also points towards the pivotal role played by 
methylation of the gene p53 in causation of URSA and hence the manipulation 
of methylation by certain agents/drugs could advantageously be used for a 
desired outcome. The level of methylation of a gene could successfully be 
altered as desired, by any methylating/demethylating agent(s) and/or drug(s), 
provided their use is devoid of causmg any side effects. 
Further study could be undertaken in a direction to design a protocol to 
either termmate unwanted pregnancies or for population control. 
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2.1 EARLY HUMAN EMBRYONIC DEVELOPMENT 
2.1.1 Fertilization 
The development of a human being starts from a single cell, a zygote, 
which results from an ovum being fertilized by a spermatozoon. Fertilization 
occurs in the fallopian tube within 48 hours of ovulation. After fertilization, a 
series of symmetrical cell divisions create a mass of 12 to 16 totipotent cells, 
the morula, which is still enclosed within the zona pellucida (Norwitz et al., 
2001; Sariola et al., 2003). The morula enters the uterine cavity approximately 
three days after fertilization. The appearance of a fluid filled inner cavity 
within the mass of cells marks the transition from a morula to a blastocyst and 
is accompanied by cellular differentiation (Norwitz et al., 2001; Wang and 
Dey, 2006). The first differentiation event gives rise to trophoblasts, 
specialized epithelial cells that give rise to extra embryonic structures, 
including the placenta. The remaining cells segregate at one pole of the embryo 
to form the inner cell mass (ICM) (Figure I). Within three days of entering the 
uterine cavity, the embryo hatches from the zona pellucida, thereby exposing 
its trophoblast cells, which enables implantation (Norwitz et al., 2001; Sariola 
et al., 2003; Wang and Dey, 2006). 
2.1.2 Implantation 
The newly formed zygote has a discrete time frame in which it must 
prepare itself for implantation. Preparation begins upon oocyte fertilization and 
takes approximately 6 to 7 days. During this time successive cell division 
occurs, and the outer trophoblast cells of the blastocyst differentiate into 
cytotrophoblasts which diverge into villous and invasive subtypes forming the 
building blocks of the placenta (Norwitz et al., 2001; Vitiello and Patrizio, 
2007). At the same time, when the blastocyst prepares itself for implantation, 
the uterus becomes receptive. Uterine receptivity is defined as the state during 
the period of endometrial maturation and proliferation when the blastocyst can 
become implanted. Multiple signals synchronize the development of the 
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blastocyst and the preparation of the uterus. From the many aspects of the 
synchronization process, the role of steroid hormones is the best understood. 
Peptide hormones, growth factors, and cytokines also have roles in the process. 
The cascade of signalling events that occur in both fetal and maternal tissues 
establishes an appropriate environment critical to the development and survival 
of the fetus (Norwitz et al., 2001; Wang and Dey, 2006; Vitiello and Patrizio, 
2007). Implantation occurs in three stages. The first stage is the initial adhesion 
of the blastocyst to the uterine wall. The next stage is characterized by 
mcreased physical interaction between the blastocyst and the uterine 
epithelium. Shortly thereafter invasion begins and syncytiotrophoblasts, the 
outer layer of the trophoblasts, penetrate the uterine epithelium (Wang and 
Dey, 2006; Chavatte-Palmer and Guillomot, 2007; Vitiello and Patrizio, 2007). 
By the 10th day after conception, the blastocyst is completely embedded in the 
stromal tissue of the uterus as the uterine epithelium has regrown to cover the 
site of implantation (Norwitz et al., 2001). The interaction between an activated 
blastocyst «uid a receptive uterus is part of a complex process that leads to 
implantation and the early stages of placental development. Failure to 
synchronize the processes involved in these interactions results in failure of 
implantation (Cross et al., 1994; Wang and Dey, 2006; Chavatte-Palmer and 
Guillomot, 2007). 
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Figure 1: Figure showing early stages of human development. A) An unfertilized 
egg cell is fertilized in the fallopian tube by a sperm cell leading to B) a fertilized 
cell containing both the maternal and paternal pronuclei. The cell undergoes 
cleavage to C) the 2-cell stage, D) the 4-cell stage and E) the 8-cell stage, which 
is reached two to three days after fertilization. F) The morula enters the uterine 
cavity approximately three days after fertilization. G) Implantation of the 
blastocyst, consisting of a blastocyst cavity, trophoblast cells and the inner cell 
mass, into the uterine epithelium is initiated around seven days after fertilization. 
(Modified from Wang and Dey, 2006. 14) 
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2.1.3 Placentation 
The placenta is the first organ to form during mammalian 
embryogenesis. The placenta is a vital organ without which the embryo cannot 
survive in the uterine environment. The function of the placenta during early 
gestation is primarily to mediate implantation of the embryo into the uterus. 
After implantation, the major function of the placenta is to mediate, as well as 
to regulate, nutrient uptake from the mother to the fetus. It also establishes the 
interface for gas exchange between the maternal and fetal circulation. Another 
important function of the placenta is the regulation of the maternal immune 
response so that the fetal semi-allograft is tolerated during pregnancy. The 
placenta also acts as an important source of hormones and growth factors that 
are needed for the initial maternal recognition of pregnancy (Cross et al., 1994; 
Cross, 2006; Sadler et al., 2006). Because the placenta is critical for survival it 
is very sensitive to disruption. Genetic or environmental factors that affect the 
development of the placenta are associated with poor pregnancy outcome. 
Abnormal expression of specific regulatory genes in the placenta and abnormal 
functions of imprinted genes may cause placental dysfunction (Coan et al., 
2005). Abnormalities in placental functions can lead to a variety of problems 
including implantation failure, placental insufficiency, fetal growth retardation 
and embryonic death. Complications that become apparent relatively late in 
pregnancy may actually reflect errors that occurred already during placental 
development (Cross et al., 1994; Rossant and Cross, 2001; Cross, 2006). 
2.1.4 Gastrulation and organogenesis 
While the syncytiotrophoblasts start to penetrate into the wall of the 
uterus during implantation, the embryoblast/ICM also continues developing. 
The embryoblast forms a bilaminar embryo, composed of the epiblast and the 
hypoblast. The hypoblast forms the yolk sac. The epiblast undergoes 
gastrulation at approximately day 16 following fertilization. Gastrulation 
establishes the three germ layers—the endoderm, ectoderm, and mesoderm— 
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all of which will give rise to various organ systems. The mesoderm also 
interacts with the trophoblast tissue to form the umbilical cord (Cross et al., 
1994; Sadler et al., 2006). At this point the actual embryonic phase starts and 
lasts from the third week until the eighth week following fertilization. The 
organ systems differentiate at greatly vaiying rates during this phase. For 
example, the circulatory system is largely functional at the end of this period, 
whereas the nervous system continues to undergo massive cell division and is 
only beginning to establish functional connections (Sadler et al., 2006). The 
remainder of human development, from weeks nine to thirty-eight, is called the 
fetal period. During this period the embryo acquires its human appearance. The 
fetal period is characterized by rapid growth and continued tissue and organ 
differentiation (Sariola et al., 2003; Sadler et al., 2006). 
2.2 RECURRENT SPONTANEOUS ABORTION (RSA) 
There are two types of miscarriage; sporadic and recurrent. In the 
general population -15% of all the clinically recognized pregnancies end in 
miscarriage (Stray-Pederson and Stray-Perderson, 1984; Nybo Andersen et al., 
2000). However, the rate of miscarriage may be as high as 50-60% if remains 
undetected, pregnancy losses occurring within the first weeks of gestation were 
taken into account by Roberts and Lowe, (1975) and Wilcox et al., (1988). Of 
the pregnancies that are lost, ~70-75% were caused by failures of implantation 
or early placentation and is therefore not clinically recognized as pregnancies. 
As a consequence, only about half of all conceptions advance into the second 
trimester of pregnancy (Rai and Regan, 2006). 
A miscarriage is a pregnancy that ends spontaneously before the fetus 
has reached a viable gestational age. Sporadic miscarriage is very common and 
25% of all women who become pregnant will experience one or more 
pregnancy losses. In the vast majority of cases these sporadic miscarriages 
occur before 12 weeks of gestation. By confrast, recurrent miscarriage (the loss 
of three or more consecutive pregnancies) is relatively uncommon, affecting 
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approximately 1% of all losses, in which case the scale of the problem 
increases to 2-3% of all couples who want to have a child. The distinction 
between sporadic and recurrent episodes of miscarriage is an important one. 
The etiological checklist for both types of miscarriages is the same, but the 
numerical contribution that genetic, anatomical, infective, endocrine, immune 
and idiopathic (unexplained) causes which results into sporadic and recurrent 
miscarriages is different. Furthermore women with a history of repeated 
pregnancy losses have reproductive characteristics associated with a poor 
prognosis for future pregnancy outcome and which distinguishes* them from 
women suffering from sporadic miscarriage. Current medical literature 
suggests that causes are identified in only -50% of patients (Plouffe et al., 
1992; Tulppala et al., 1993a; Clifford et al., 1994; Katz & KuUer, 1994). The 
identifiable causes can be categorized into genetic, anatomical, environmental, 
endocrinological and immunological categories. 
2.2.1 Maternal diseases 
Maternal diseases including diabetes mellitus, systemic lupus 
erythematosus, thyroid disease, chronic essential hypertension and renal 
diseases appear to increase the risk for RSA. A case of prolonged 
hypoparathyroidism presenting as second trimester miscarriage has been 
reported by Eastall et al, (1985). However, current evidence suggests that well-
controlled diabetes mellitus or treated thyroid dysfimction is not associated 
with RSA (Clifford et al., 1994). 
2.2.2 Genetic Factors 
i) Parental Chromosomal Anomalies 
Parental chromosomal anomalies occur in -4% of couples with recurrent 
spontaneous abortion as opposed to 0.2% in the normal population. The most 
common abnormality is a balanced translocation, including reciprocal and 
Robertsonian translocations resulting in unbalanced translocation in the fetus 
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(Stirrat, 1990; Tulppala et al., 1993a; Clifford et al., 1994). However, 
chromosomal anomaly detected using conventional karyotyping techniques 
represents the 'tip of the iceberg' phenomenon. It is possible that unidentified 
micro-deletion or otiier subtle chromosomal aberrations may contribute to 
RSA. 
ii) Hyperhomocysteiaaemia 
Homocysteine is a sulphydiyl nonessential amino acid whose 
metabolism is normally tightly regulated. In a number of inherited and acquired 
conditions the levels of homocysteine are increased. Hyperhomocysteinaemia 
is associated with the development of venous and arterial thrombosis (Makris, 
2000). Homocysteine levels fall during normal pregnancy and this fall is 
independent of folate intake during the pregnancy (Bonnette et al., 1999). High 
homocysteine levels have been associated with a number of pregnancy-related 
complications including neural tube defects, placental infarcts, fetal grov^ 
retardation as well as placental abruption. Nelen et al., (2000a) recently 
published a meta-analysis showing a significant association between 
hyperhomocysteinaemia and recurrent early pregnancy loss. It has been 
suggested that maternal hyperhomocysteinaemia interferes with embryonic 
development through defective chorionic villous vascularization (Nelen et al., 
2000). Folate deficiency is one of the commonest acquired causes of 
hyperhomocysteinaemia. Among the genetic causes a common one is 
polymorphism at position 677 in the methyl tetrahydrofolate reductase 
(MTHFR) gene which in the homozygous form leads to a thermolabile enzyme 
variant. The thermolabile variant is found in 15% of the normal population and 
in association with folate levels in the lower part of the normal range leads to 
hyperhomocysteinaemia (Makris, 2000). 
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iii) Heritable ThrombophUia 
There are five currently recognized heritable thrombophilic defects. 
These are deficiencies of anti-throrabin, protein C or protein S as well as the 
factor V Leiden and pro-thrombin 202 lOA variant. Factor V Leiden can be 
detected using either a coagulation-based assay (activated protein C resistance) 
or by direct demonstration of the Arg 506 Ghi change in the factor V gene. 
iv). Other Hematological Abnormalities 
A number of other coagulation abnormalities have been reported to be 
associated with RSA, including impaired fibrinolytic activity (Gris et al., 
1995), factor XII deficiency (Daya, 1994; Ogasawara et al., 2001) and reduced 
activated partial thromboplastin (Ogasawara et al., 1998). Essential 
thrombocythaemia is known to be associated with an increased risk of fetal loss 
(Griesshammer et al., 1996; Wright and Tefferi, 2001). 
2.2.3 Anatomical Causes 
i) Congenital uterine Anomaly 
Among the various congenital structural uterine anomalies, the septate 
uterus is the most common. There is little doubt that the septate uterus is 
associated with an increased risk of miscarriage due to impairment or 
implantation (Homer et al., 2000). It is now recognized that the septum 
is rather vascular. Fedele et al., (1996) used SEM to compare 
endometrial biopsy specimens obtained fi-om the septum and the lateral 
uterine wall in the pre-ovulatory phase. They found that the septal 
endometrium showed defective development, indicative of a reduction 
in the sensitivity to steroid hormones. 
it) Asherman's Syndrome (endometrial fibrosis) 
Asherman's syndrome is an acquired condition, which is due to the 
presence of post-traumatic intrauterine adhesions, partly or completely 
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obliterating tiie uterine cavity. Endometrial responsiveness to steroid 
hormones is reduced in areas affected by intrauterine adhesions or 
fibrosis. A lesser degree of damage to the endometrium may produce 
patchy fibrosis without a significant amount of intrauterine adhesion, 
which is sometimes referred to as partial or incomplete Asherman's 
syndrome. Successful division of the intrauterine adhesions in cases 
without extensive fibrosis may restore the responsiveness of the 
endometrium and lead to regular menstruation. However, the presence 
of extensive dense fibrosis indicates a poor prognosis. 
iii) Uterine jfibroid 
Uterine fibroid may also affect implantation and increase the risk of 
miscarriage. It has been suggested that reproductive outcome is 
significantly compromised with sub mucous fibroids (i.e. fibroids 
distorting the cavity), modestly compromised with intramural fibroids, 
and possibly compromised with sub serosal fibroids (Seoud et al., 1992; 
Farhi et al., 1995: Eldar-Geva et al., 1998: Ramzy et al., 1998; Stovall et 
al., 1998; Bajekal & Li, 2000: Hart et al.,2001). It appears fi-om number 
of retrospective and cohort studies that there is good evidence, that 
removal of sub mucous fibroids reduces miscarriage rate and there are 
also some evidence that removal of intramural fibroids also reduces 
miscarriage rate (Bajekal & Li. 2000). 
2.2.4. Environinental Factor's 
Pentachlorophenol (PCP) a compound, present in certain types of timber 
preservative, has been reported as a possible cause of miscarriage. Serum PCP 
level may be measured and should not exceed 25 mg/ml (De Maeyer et al., 
1995). Heavy metals, organic solvents, and ionizing radiation are confirmed 
teratogens, and exposure to these can contribute to pregnancy loss (Dhont, 
2003). Alcohol and cocaine are also confirmed teratogens, while caffeine and 
smoking are suspected teratogens but their teratogenic impact is still 
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controversial (Dominguez-Rojas et al., 1994; Parazzini et al., 1998; Cnattingius 
et al., 2000; Kesmodel et al., 2002). 
2.2.5. Stress 
Psycho-neuro-endocrinological or psycho-neuro-immunological 
pathways have been proposed as possible mechanisms in which stress may 
contribute to miscarriage. The relationship between stress and corpus luteal 
dysfunction has been reviewed (Li & Cooke, 1991). Whereas the relationship 
between stress and immune mediators in miscarriage was examined recently 
(Arck et al., 2001). These investigators studied the decidual tissue of women 
with first trimester miscarriage and found that women with high stress scores 
had a different pattern of immunocompetent cells than women with low stress 
scores. 
2.2.6. Microbial Infections 
Infections appear not to play a significant role in first trimester RSA. 
The infection is an occasional cause of sporadic spontaneous abortion and, 
consistent with statistical probability, RSA due to infection must be rare 
(Summers, 1994). Chorioamnionitis, however, may be a cause of premature 
labor and mid-trimester loss. 
2.2.7. Smoking and Alcohol 
Smoking has been reported to be associated with RSA (Dominguez-
Rojas et al., 1994). There are conflicting studies about the association between 
alcohol consumption and miscarriage. 
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2.2.8. Endocrinological Disorders 
i) Luteinizing Hormone 
The hyper secretion of Luteinizing Hormone (LH) has been 
considered as a marlcer of miscarriage (Homburg et al., 1988; Regan 
et al., 1990). A number of studies examined the prevalence of high 
LH levels and polycystic ovaries (PCO) among women with RSA 
(Sagle et al., 1988; Clifford et al. 1994; Carp et al., 1995; Bussen et 
al.. 1999; Li etal., 2000). 
ii) Androgen Levels 
Two recent studies have shown that androgen levels in the follicular 
phase are higher in RSA women as compared in normal fertile 
controls (Okon et al., 1998; Bussen et al., 1999). The observation is 
independent of the association between polycystic ovarian disease 
and RSA. The androgens cause an increase in epidermal growth 
factor receptor, concentration (Watson et al., 1998) and reduce the 
secretory activities of glandular cells as measured by glycodelin A 
production in a dose dependent fashion (Tuckerman et al., 2000), 
which suggest an adverse effect of androgens on endometrial 
glandular cell function. 
iii) Primary Endometrial Defects 
Suboptimal progesterone production and uterine pathology may 
result in endometrial defects. A steroid receptor defect may be an 
explanation for the observed abnormality. The preliminary results 
using immunohistochemistry suggests that steroid receptor 
abnormalities may be present in a small sub-population of women 
with unexplained RSA. However ftirther investigations are required 
for identification of these differences by steroid receptor 
immunohistochemistry alone is not sufficiently precise. 
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1.1.^, Immunological Factors 
Since the conceptus displays paternal gene products and antigens, it is 
possible that the maternal immune system recognizes these as foreign, resulting 
in an immune response (Dalton et al., 1998; Hill and Choi, 2000). Survival of 
the semi-allogenic fetus is dependent on suppression of the maternal immune 
response and miscarriage may be a consequence of a failure of this 
suppression. It is assumed that both maternal and embryonic regulating factors 
protect the embryo against an adverse maternal immunological reaction. 
Maternal adaptation to the implanting embryo is needed for successful 
establishment of the fetal-placental unit, and the embryo must be able to 
stimulate an immunological reaction from the mother in order to become 
protected from cytotoxic molecules (Bulletti et al., 1996; Li et al., 2002b; 
Pandey et al., 2004). The mechanism by which the fetus escapes rejection by 
the maternal immune system is unknown. However, differences in the 
concentration of circulating immunocompetent cells, such as natural killer 
(NK) cells, and cytokines have been reported between RM women and controls 
(Wegmann et al., 1993; Reinhard et al., 1998; Ntrivalas et al., 2001; Yamada et 
al., 2001). The immunological factors are very important in etiology, of 
recurrent spontaneous abortion as well as unexplained RSA. We will discuss all 
these factors in three major heads: 
a) Natural Killer Cells 
Natural killer (NK) cells are lymphocytes involved in the innate Immune 
response against certain microbial and parasitic infections (Scott & 
Trinchieri, 1995; Biron, 1997). These cells comprise 5-20% of peripheral 
blood lymphocytes and are present in spleen, liver, bone marrow, and 
thymus at a lower frequency and are rare in lymphatic and lymph nodes. 
However, in the mucosal decidual tissues of the maternal uterus, NK 
cells are the most abundant class of lymphocyte, representing up to 95% 
of all lymphocytes. Initially identified by their distinct morphology, NK 
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cells in the placenta were designated "granulated metrial gland cells" in 
rodents (Parr et al., 1990) and "uterine granular lymphocytes" in humans 
(Buhner & Sunderland, 1983; King & Loke, 1991). Why do NK cells 
preferentially accumulate in the decidua? No clear rationale has emerged 
to explain this phenomenon. Given the established role of NK cells in 
innate immunity, protection of the fetus against trans-placental infections 
is a good bet, but non-immune functions involving fetal sustenance have 
also been proposed (Guimond et al., 1998). 
i) Uterine natural killer cells 
Natural killer cells (identified by the surface marker CD56) are the 
dominant type of maternal immune cell populating the uterine mucosa 
during formation of the placenta (Moffett-King, 2002). These uterine 
NK cells are also present in the endometrium of non-pregnant women, 
when they are under the control of ovarian hormones, cycling together 
with the glandular and stromal compartments. After ovulation, uterine 
NK cells proliferate vigorously so that by the late secretory phase they 
account for at least 30% of the endometrial stroma. Uterine NK cells 
persist in the early decidua and accumulate in large numbers at the 
implantation site. Here they are in close contact with the invading 
placental trophoblast cells, which transform the spiral arteries into high 
conductance vessels. This transformation is essential to ensure a normal 
blood supply to the fetus and placenta throughout pregnancy. Of central 
importance is that uterine NK cells are phenotypically and functionally 
different from NK cells in peripheral blood and should be regarded as a 
separate lymphoid subset. The presence of an apparently unique type or 
lymphocyte in the uterus at implantation and during early placentation is 
intriguing. However despite much speculation, the function of uterine 
NK cells is completely unknown. They may affect the cycling 
endometrium by controlling vascular function through secretion of 
angiogenic growth factors. In this way they may be crucial in the 
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decision to switcli from endometrial breakdown (menstruation) to 
decidualization in pregnancy (King, 2000). More attention has been 
directed at their possible role in regulating the fetal supply line by 
modulating the structural adaptation of the uterine spiral arteries. This is 
achieved by invasion of the maternal decidua and adjacent myometrium 
by invasive fetal trophoblast cells. Trophoblast invasion is defective in 
intrauterine growth restriction, pre-eclampsia, and miscarriage 
(Pijnenborg et al., 2002). How NK cells recognize trophoblast and the 
outcome of this recognition are under investigation. Recently, the NK 
cell receptors that can bind to trophoblast MHC class I molecules have 
been identified, and this has opened up new ways to study the function 
of uterine NK cells (Parham, 2004; Hiby et al, 2004). At present, 
despite their compelling name, there is no evidence that uterine NK cells 
kill placental trophoblast cells. Instead, they probably have an essential 
beneficial effect on trophoblast by secreting cytokines that alter the 
depth of placental invasion. Natural killer cells acquired their name as a 
result of the initial test used to identify them in vitro. Unlike, T 
lymphocytes NK cells are able to spontaneously kill cells in a non-
MHC-restricted manner. Re^ettably, this is a misleading name in 
reproduction, and the powerful image of maternal cells attacking the 
fetus is emotive and easily exploited. 
ii) Uterine NK cells in pregnancy failure 
Attempts have also been made to compare the number of NK cells in the 
non- pregnant endometrium of women with recurrent miscarriage or 
infertility with that in normal controls (Shimada et al., 2004; Quenby et 
al., .1999). Normally, numbers of uterine NK cells change rapidly after 
ovulation, and quantification must be carefully correlated with the surge 
m luteinizing hormone. Furthermore, the density of NK cells throughout 
the mucosa is not constant, so all samples should be analyzed at the 
same depth beneath the surface epithelium. 
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b) Major Histocompatibility Complex 
MHC-class-I-specific NK cell receptors comprise two very different 
utilities of molecules (Table I) one made of immunoglobulin super family 
(Ig-SF) domains, and the other resembling C-type lectins (i.e. in the C-type-
lectins-domain family [CTLD]). In humans, 14 killer Ig-like receptor 
(KDFZ) genes are clustered in a 150 kb region of human chromosome 19 
called the leukocyte receptor complex (LRC). KIRs are characterized by the 
number of Ig domains (2D or 3D) and by the length of their cytoplasmic 
tail. Long-tailed KIRs (2DL or 3DL) contain immunoreceptor tyrosine-
based inhibition motifs (ITMs), which recruit the phosphatase SHP-1 upon 
receptor engagement and induce inhibitory signals. Short-tailed KIRs (2DS 
or 3DS) lack ITMs and send activating signals to NK cells by association 
with the adaptor signaling molecule DAPI2 via a charged amino acid in the 
trans-membrane region. Some KIRs have specificity for epitopes of HLA, 
the human MHC class 1 molecules, whereas the ligands for other receptors, 
particularly the activating KIRs, have not been determined (Vilches and 
Parham, 2002). Rodents lack KIRs, and instead use structurally distinct 
Ly49 CTLD receptors to bind MHC class I molecules on target cells. 
Members of the Ly49 gene family (Ly49a-w) are located in the NK cell 
gene complex (NKC) on mouse chromosome 6. The Ly49 family includes 
both inhibitory and activating receptors, and some have specificity for 
mouse MHC class (Adam and Parham, 2001). The genomes of non rodent 
mammals, including humans, contain a single Ly49-like gene (Ly49L). 
Point mutations have inactivated the Ly49L gene in higher primates 
(gorilla, chimpanzee and humans), but in other species (cow, baboon and 
orangutan) it appears to be functional (Mager et al., 2001; McQueen et al. 
2002; Guethlein et al., 2002). Thus, Ly49 genes predate the divergence of 
placental mammals; but expansion of the gene family may be unique to the 
rodent lineage. NK cells also express receptors that recognize non-classical 
MHC class I molecules. Inhibitory and stimulatory CD94-NKG2 
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heterodimers (containing NKG2A, C, E or F) belong to the C-type-lectins 
super family and their genes are located in the NKC (Houchins et al; 1991; 
Vance et al., 1997; Lohwasser et al., 1999; Vance et al., 1998). The 
organization of the CD94 and NKG2gene cluster is similar in humans and 
mice and although CD94 and NKG20 appear orthologous, that is not the 
case for the otiier NKG2 genes (Vance et al., 1999). hi humans, CD94-
NKG2A and C receptors interact with complexes consisting of the non-
classical HLA-E molecule bound to a peptide derived from the leader 
sequence of a classical HLA class I protein (Borrego et al., 1998; Braud et 
al., 1998; Lee etal., 1998). 
Evidence from several quarters supports the view that decidual NK cells 
cooperate with extra villous trophoblasts express MHC class 1 molecules 
and those they express HLA-C, E and G are good ligands for NK cell 
receptors (Trundley & Moffett, 2004). HLA-G is expressed only by extra 
villous trophoblasts and medullary epithelial cells or the thymus (Le 
Bouteiller et al., 2003), whereas HLA-C and HLA-E have ubiquitous 
distribution. HLA G is the LILRBl ligand, HLA-E is the ligand for CD94-
f^KG2A/C (King, 2000), and HLA-C ligands engage several members of 
the KIR family (Vilches & Parham, 2002). 
c) Cytokines 
Cytokines are small, usually glycosylated proteins expressed and secreted in 
a highly regulated fashion, with the flexibility to act locally or at a distance, 
to limit their sphere of influence or act at a systemic level, and to exert 
transient or sustained effects. Cytokines have traditionally been divided into 
families dependent upon the origin of immune cell and the immunological 
effects that they bring about. CD4+ T- helper cells are the major immune 
cells involved in cytokine production, and these can be divided into three 
functional subsets based on their cytokine production. Th 1 cells produce 
interferon gamma (IFNy), IL-2 and tumor necrosis factor beta (TNFp) and 
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these are the main effectors of cell mediated immune responses. Th 2 cells 
produce IL-4, IL-5, IL-6 and IL-10, which are the main effectors of 
antibody- mediated humoral responses. The third T-helper cell population is 
that of the Th 0 cells; these are precursor cells which can be converted to 
either Thl or Th2 type cells and can produce both Th 1 and Th2 cytokines as 
well as TNFa and granulocyte- macrophage colony stimulating factor (GM-
CSF) further family of cytokinesis, the pro-inflammatoiy cytokines, such as 
IL.-l, TNFa, IL-6 and leukemia inhibitory factor (LBF); these are produced 
by macrophages and are involved in the inflammatory events associated with 
tissue damage and repair. It is now known that all these cytokines are also 
produced by cells other than immune cells, including the epithelial and 
stromal cells of the endometrium and the decidual and cytotrophoblast cells 
of the placenta. This is particularly pertinent to their potential role in 
reproductive failure. As T-helper cells are only a minor population of cells 
within the secretory endometrium and first-trimester placental tissue and 
therefore may not be the main source of cytokines present in the feto-
placental unit. The cytokine network operating in the female reproductive 
tract is governed predominantly by ovarian steroid hormones, and it is 
through the agency of cytokines that reproductive hormones exert their 
powerful influence on local immune activity (Robertson et al., 1994). During 
the oestrous cycle and pregnancy, fluctuating concentrations of ovarian 
steroid hormones have a marked effect on the pattern of cytokines emanating 
from endometrial somatic cells, particularly luminal and glandular epithelial 
cells. Further modulation of the cytokine occurs in response to insemination 
(Robertson et al.. 1992; Choudhuri & Wood, 1993; Tremellen et al., 1998), 
the presence of a conceptus (Cocchiara et al., 1996) or during the 
introduction of foreign agents or infections (Rasmussen et al., 1997). 
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Table I 
Characteristics of NK cell receptor families. 
NK Receptor family 
KIR 
ILT/LIR 
CD94/NKG2 (KLR) 
NKG2D (KLRK) 
NCR 
Molecular 
Nature 
Ig- super family 
Ig- super family 
C-type lectins 
C-type lectins 
Ig- super family 
Genetic 
complex 
LRC(19ql3.4) 
LRC 
NKC (12pl2.3-
3.2) 
NKC 
Various 
including MHC, 
LRC 
Ligands 
HLA-A,Bw,Cw 
HLA Class la (-G) 
HLA Class lb (-E) 
MIC and MHC class 
l-like 
Viral 
haemagglutinins & 
others 
(Adopted by Biassoni et al., 2003) 
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2.3. Unexplained RSA 
The cause of miscarriage in -50% of women with RSA remains 
unexplained despite of thorough investigations. A number of possible 
etiologies have been proposed to explain the occurrence of RSA in patients in 
whom there does not appear to be any obvious cause. Repeated sporadic fetal 
chromosomal anomalies occurring by chance, such as repetitive fetal 
aneuploidies due to increasing maternal age, may be responsible for 
unexplained RSA (Stirrat, 1990). Several studies suggest that fetal 
chromosomal anomalies account, for -50% of sporadic first trimester 
miscarriage, and possibly a similar proportion of RSA. Miscarriages due to 
abnormal karyotypes often occur before 10 weeks gestation, including cases 
with fetal heart occurring after 10 weeks gestation is less likely to be associated 
with significant chromosomal anomalies. Women over the age of 37 years are 
more likely to have miscarriages associated with fetal chromosomal anomalies, 
as a resuh of age-related decline in oocyte quality. Ogasawara et al. (2000) 
found that the frequency of normal embryonic karyotypes significantly 
increases with the number or miscarriages. The observation indirectly suggests 
that as the number of miscarriage increases, maternal factors involved in 
embryo-endometrial dialogue may become increasingly responsible for 
pregnancy failure. HLA sharing in couples, especially HLA-B and DR has 
been proposed as a possible explanation for unexplained RSA (Edmonds et al., 
1982). Two recent studies suggested a link between HLA class II phenotypes 
and anti phospholipids antibodies in women with RSA (Christiansen et al., 
1998; Hataya et al., 1998). Further studies are required to establish the role 
played by genetic factors in unexplained RSA. Histological examination of 
endometrial biopsy in the luteal phase is the, classic method used to evaluate 
endometrial receptivity. A number of studies have shovm that unexplained 
RSA is associated with abnormal morphological development of the 
endometrium in the luteal phase. Moreover, there is also biochemical evidence 
to suggest the existence of an endometrial factor in unexplained RSA (Tulppala 
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et al, 1995).The levels of endometrial protein glycodelin A were found to be 
reduced in plasma and in uterine flushings of women with RSA (Dalton et al., 
1995). In addition, the amount of glycoprotein MUC-1 was also found to be 
reduced in the endometrium of women with unexplained RSA (Hey et al., 
1995). 
2.4. Epigenetics: 
The term "epigenetics" defines studies of heritable changes in gene 
expression and chromatin organization that are not encoded in the genomic 
DNA itself. Epigenetic inheritance represents a critical mechanism that allows 
a remarkably stable propagation of gene activity states over many cell 
generations. Epigenetic information that fulfils the criterion of heritability can 
be classified into three distinct types: DNA methylation, histone modifications, 
and non-coding RNAs. 
2.4.1 DNA Methylation 
DNA methylation refers to a covalent modification of the cytosine base 
(C) that is located 5' to a guanine base (G) in the CpG dinucleotide. The 
transfer of methyl groups fi-om S-adenosyl-1-methionine (SAM) to cytosine in 
CpGs is catalyzed by several DNA methyl transferases (DNMTs). The 
methylation of DNA has multiple roles in cellular processes, including 
regulation of gene expression (Bird, 2002). Aberrant DNA methylation is 
universally present in human malignancies and is associated with inappropriate 
gene expression (Feinberg et al., 2004). 
Histone (chromatin) modifications define covalent posttranslational 
modifications of histone proteins. The fundamental unit of chromatin is the 
nucleosome, which consists of 146 base pairs of genomic DNA wrapped 
around an octamer of 4 core histones. 
Methylation changes in DNA play a role very similar to that of genetic 
mutations m cancer; however, unlike a genetic alteration, DNA methylation is 
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potentially reversible with pharmacologic intervention. DNA methylation is 
critically dependent on continued expression of DNA methyltransferases. 
Hence, inhibition of the expression of these proteins would therefore result in 
progressive reduction in DNA expression of these proteins would therefore 
result in progressive reduction in DNA methylation in newly divided cells, a 
phenomenon associated with reactivation of gene expression in 
hypomethylated cells (Egger et al., 2004). Genomic imprinting is an epigenetic 
mechanism resulting in monoallelic expression of a gene depending on its 
parent of origin. It renders the two parental alleles functionally non- equivalent. 
Transcriptional silencing of mammalian genes is mediated by at least two 
modes of methylation: (1) cytosine methylation of DNA, and (2) methylation 
of the histones tails—both of which play an important role in transcriptional 
silencing from chromosomal DNA. Although there is some evidence that these 
pathways are interdependent, experimentally, they have largely been treated as 
two distinct processes. Smallwood et al. (2007) have taken a pioneering step 
toward defining the molecular mechanism by which these two types of 
methylations can cooperate to silence a euchromatic gene, and demonstrate that 
the DNA methyl transferase 1 (DNMTl) cytosine methyltransferase physically 
and functionally interacts with three Heterochromatin Protein 1 (HPl) family 
members ( a, P, and y) to implement gene silencing. DNA methylation is 
required for normal development in mammals. It is brought about by the de 
novo methyl transferases DNMT3a and DNMTSb and is propagated by the 
maintenance methyl transferase DNMTl (GoU and Bestor 2005). DNA 
methylation is associated with silencing repetitive elements in the genome, X-
chromosome inactivation in female mammals, and silencing of individual 
genes during development (Li and Bird 2007). Furthermore, DNA methylation 
is misregulated in cancer cells such that tumor suppressor genes are silenced to 
favor the growth of the tumor while repetitive regions of the genome are 
desilenced, which can contribute to genomic instability (Jones and Baylin 
2007). However, a study by Liu et al., (2008) reported the molecular 
mechanism of DNA methylation during bovine cloning in which the aborted 
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cloned fetuses exhibited abnormal methylation imprints, which partially 
accounted for the higher abortion and developmental abnormalities. 
Extremely skewed X-chromosome inactivation patterns in women 
studied by Bagislar et al, (2006) showed disturbances in XCI mosaicism to be 
involved in the pathogenesis of RSA. 
2.4.2 DNMTl 
A recent study by Okuwaki and Verreault (2004) demonstrated that 
DNMTl is capable of de novo methylation of nucleosomal DNA of 5S rRNA 
genes. This demonstrates a new capability of DNMTl outside S phase. 
Similarly, Easwaran et al. (2004) have demonstrated replication-independent 
chromatin loading of DNMTl during G2 and M phases of mammalian cells to 
constitutive heterochromatin. This observation has implications m chromatin 
silencing. The recruitment of G9a to DNMTl perhaps coordinates histone and 
DNA methylation long after DNA replication. Furthermore, due to the low 
catalytic turnover of DNMTl (Pradhan et al. 1999) stimulation by G9a may aid 
DNA methylation. This hypothesis is evident in genetic knockout of G9a, 
resulting in reduction of H3K9 methylation in Prader-Willi syndrome 
imprinting center and loss of maternal-specific CpG methylation of Prader-
Willi syndrome imprinting center in mouse ES cells (Xin et al. 2003). These 
findings support a possible role for both G9a and DNMTl in the establishment 
of histone and DNA methylation. Esteve et al., (2006) showed that two global 
epigenetic enzymes, DNMTl and G9a, coordinate synchronized DNA and 
histone H3K9 methylation during DNA replication (fig.2). Whereas, work of 
Jackson-Grusby et al., (2001) showed that cre-mediated deletion of DNMTl 
induces p53-dependent apoptosis. Further work of Esteve et al (2006) proved 
that the normal methylation of replicating chromatin could be disturbed by 
knockmg down of DNMTl with the help of small interfering RNA (siRNA) 
despite the presence of G9aMT, which proves that G9aMT alone could not 
maintain normal DNA methylation/silencing of related genes. 
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Figure 2. Model for the interactivity between epigenetic modification systems. 
Smallwood et al. (2007) present evidence for the concerted activity of DNA 
methylation and histone methylation in the silencing of a euchromatic gene. They 
propose a model in which HPl first binds to Lys 9 of H3 (K9) that has been 
methylated by G9a histone methyltransferase. HPl interacts with DNMTl and 
stimulates its methylation at CpG dinucleotides (blue circles). DNMTl stabilizes 
HPl binding to chromatin and makes further interactions with G9a, providing 
multiple points of cooperation for gene silencing. 
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2A3 G9a Methyltransferase: Role in implantation 
It has been shown that the histone methyl transferase (HMTase) 
responsible for methylation of Arg 2, Arg 17, and Arg 26 in H3 (Ma et al. 2001; 
Xu et al. 2001) and Arg 3 in H4 (Strahl et al. 2001; Wanget al. 2001b) plays an 
important role in the transcriptional activation of certain genes. Methylation of 
Lys 4 in H3 (H3-K4) localizes to heterochromatin boundaries and 
transcriptionally active loci (Litt et al. 2001; Noma et al. 2001). In contrast, 
current evidence suggests that H3 Lys 9 (H3-K9) methylation is responsible for 
the creation of transcriptionally repressive heterochromatin (Rea et al. 2000). 
Pericentric heterochromatin contains enriched HPl proteins from specific 
interaction between methylated H3-K9 and the chromo domain of HPl 
(Bannister et al. 2001; Lachner et al. 2001). Clr4 in yeast (Nakayama et al. 
2001) and Suv39h in mammals (Aagaard et al. 1999; O'Carroll et al. 2000), 
which are counterparts of Drosophila melanogaster Su(var)3-9 protein, are 
major heterochromatic H3-K9 HMTases and play a dominant role in pericentric 
heterochromatin formation. The pericentric heterochromatin architecture also 
plays crucial roles in chromosomal segregation as well as in establishing 
transcriptional repression. According to this notion, the loss of Suv39h 
HMTases abolished H3-K9 methylation at pericentric heterochromatin, 
inducing chromosomal instability (Peters et al, 2001). The evidence that G9a, a 
mammalian HMTase, is a candidate for H3-K9 methylation in non 
heterochromatic loci was provided by Tachibana et al. (2001). In vitro 
experiments showed that G9a had a 10-to 20-fold stronger HMTase activity 
toward H3-K9 compared to Suv39hl, and also that it could methylate Lys 27 of 
H3 (H3-K27) as well as K9, whereas the targeting site on H3 for Suv39hl was 
solely Lys 9. Localization analysis of G9a in nuclei suggested that this HMTase 
might target sites at transcriptionally active euchromatin rather than repressive 
pericentric heterochromatin. To investigate the in vivo function(s) of G9a, we 
generated G9a-deficient mice and ES cells. Here, we show that G9a is essential 
for early embryonic development and plays a dominant role in H3-K9 
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methylation of euchromatin. Moreover, G9a can exert transcriptional repression 
in vitro, a function that depends on its HMTase activity. Tachibana et al (2002) 
data suggest that the euchromatic H3-K9 methylation regulated by G9a is 
involved in the transcriptional silencing of developmentally regulated genes. 
G9a genes were mapped within the major histocompatibility complex 
class III region in mouse and human (Brown et al. 2001). Tachibana et al 
(2002) also reported Lethality and severe growth/developmental defect of G9a-
deficient embryos and also Loss of H3-K9 methylation leads to accumulation 
of acetylated H3-K9 and methylated H3-K4. 
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Figure 3: Model for chromatin methylation by the DNMT1/G9a complex. 
(^)During DNA replication, the PCNA-DNMTl complex recruits G9a. As the 
replication fork moves, concurrent events of maintenance DNA methylation of 
hemi-methylated DNA takes place along with G9a-mediated H3K9 dimethylation. 
Unmethylated and methylated CpGs are shown as open and closed loUypops. 
Cofactor AdoMet is used as a methyl donor. (B) Post-replicative chromatin 
methylation involves DNMT1-G9a and DNMT1-SUV39H1 complexes. SUV39H1 
can bind to H3K9me2 (blue-filled stars) using its chromodomain and catalyzes 
H3K9 trimethylation. DNMTl can methylate unmethylated CpG sites. G9a-
DNMTl complexes can bind to H3K9me2 (an intermediate product) with a lower 
affinity for H3K9 trimethylation reaction (H3K9me3, filled stars). The presence of 
G9a in a DNMTl complex will activate DNMTl catalysis for additional de novo 
methylation (methylation spreading) as seen in silenced genes in cancer cells. (C) 
Methylation-independent gene repression and heterochromatic localization of 
SUV39H1 and DNMTl. Following post-replicative chromatin methylation, the 
heterochromatin components of the nucleus are enriched with H3K9me3, which 
serves as a platform for HPl binding. HPl recruits SUV39H1 and DNMTl for 
repressor complex formation. DNMTl is shown to recruit other repressor 
components such as HDACl. However, the methylated chromatin may get 
demethylated to feed into the methylation cycle. [Esteve et al., (2006)] 
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2.5. Apoptosis 
Each living cell undergoes cell cycle regulation where an essential 
assessment mechanism occurs to determine the status of the cell, whether it is 
healthy enough to continue towards the next stage of cycle or whether it should 
commit suicide. 
Apoptosis is generally defined as a programmed cell death that 
eliminates unwanted cells and is essential for the homeostatic maintenance of 
an organism. Like cell proliferation, cell death needs to take place in order for 
normal development to take place. It has been found that elevated levels of 
apoptosis as well as low levels of apoptosis can have a detrimental effect on the 
organism. This impaired regulation of apoptosis leads to a variety of 
pathological conditions, such as neuro-degeneration, autoimmunity, chronic 
inflammation, AIDS, and cancer. In the eukaryotic cell cycle there are four 
stages, the Gap-1 checkpoint (G-1), DNA Synthesis (S-phase), Gap-2 
checkpoint (G-2), and the Mitotic phase (M) (Figure 4). Cyclin-cdks regulate 
the cell through each phase. The G-1 and G-2 checkpoint phases are where the 
cell assesses whether to proceed to the next stage or commit suicide. The ceil 
cycle results in either of two processes, which is either to proceed to the next 
stage (cell division) or to induce apoptosis (cell suicide), which is determined 
by the p53 protein. There are two pathways by which a cell commits suicide: 
(1) the intrinsic or mitochondrial pathway and (2) the extrinsic or death 
receptor pathway. (Zimmermann and Green, 2001) 
2.5.1. Tumor Suppressor: pS3 
Tumour suppressor genes are inactivated by genetic or epigenetic 
changes such as point mutations, deletions, promoter methylation, abnormal 
splicing, deregulation of imprintmg and haplo-insufficiency (Kuroki et al., 
2002). 
%i4€YiUr JS^ ^ UtneuK^^tieraturgd 
p53 (a protein with molecular weight -53 kDa) is a tumor suppressor 
that halts progression in both the Gl and G2 phase of the cell cycle to assess 
DNA damage (Figure 5). If damage has occurred p53 determines whether 
damage can be repaired and if so, triggers cell cycle arrest until the damage is 
repaired. If damage is irreparable, they trigger apoptosis (Figures 4and 5). Cell 
cycle therefore results in either of two processes, either to proceed to the next 
stage (DNA synthesis or cell growth) or to induce apoptosis (cell suicide). 
Mutations in these checkpoint genes result in defective proteins and 
unsuccessful checkpoints occur. Cells then complete mitosis but aberrant 
daughter cells arise which leads to diseases where uncontrolled cell growth 
occur, such as cancer. 
Somatic alterations of p53 abolish its ability to activate p21, Bax, and 
PIG3 reporter systems, thus altering cell cycle control and apoptosis overall 
(Robert et al., 2000). 
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Figure 4: Simple schematic diagram of normal cell cycle progression leading 
to Mitosis (M) or cell growth (if DNA is intact) or Apoptosis (if DNA damage 
occurs). 
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pS3 and the Cell Cycle 
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Figure 5: Role of p53 in cell cycle: mediator between cell growth and death, (i) 
During each checkpoint of the cell cycle, the cell cycle is arrested for p53 (and 
other tumor suppressor genes) to check if DNA damage has occurred. If DNA 
damage has occurred p53 halts the cell cycle at the checkpoint and signals 
appropriate proteins to repair damage. Once damage has been repaired, p53 
signals cell to proceed to next phase of cell cycle, (ii) If DNA damage is 
irreparable, p53 signals apoptotic inducing factors (AIF), like the Bcl-2 family, 
to induce apoptosis, rather than proliferate and cause damage to the organism, 
e.g. cancer. 
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2.5.2. Apoptosis: Role in Pregnancy 
Apoptosis is a process by which single cells undergo death and deletion 
from a tissue. This is characterized by cell shrinkage, dramatic reorganization 
of the cell nucleus, active membrane blebbing and fragmentation into 
membrane-bound vesicles known as apoptotic bodies (Wyllie et al., 1980). The 
cell remains and the apoptotic bodies are then phagocytosed through 
inflammatory reactions. Apoptosis is an essential feature of normal physiology 
in a variety of organs and is reported to play an important role in fetal 
development (Thompson, 1994). hi contrast many cells within a tissue are 
characterized by an inflammatory reaction. The regulation of apoptosis is 
complex and involves a family of related proteins which display either positive 
or negative regulatory effects. The proto-oncogene product bcl-2 is the 
prototype product of a family of genes associated with the inhibition of 
apoptosis (Wyllie, 1994), Level of control is through the interaction of bcl-2-
related apoptosis inhibitors and apoptosis promoters, e.g. bax (Oltavi et al., 
1993). 
There is increasing evidence that regulated apoptosis is important during 
implantation in early pregnancy. Implantation and decidualization in the rat 
have been associated with the progressive induction of apoptosis in the 
decidual cells lining the embryo, and decidualization in response to an artificial 
stimulus has been associated with an increased expression of bax and a 
decreased expression of bcl-2 (Parr et al.,1987; Piacentini and Autori, 1994; 
Akcali et al., 1996) In the human placenta, bcl-2 has been immunolocalized to 
the syncytiotrophoblast of the chorionic villi and appears to persist from the 
first trimester through to the third trimester of pregnancy (Sakuragi et al., 
1994). Indeed, Sakuragi et al., (1994) proposed that this may be one 
mechanism by which trophoblast mass is preserved during pregnancy. 
There have been several studies of normal endometrial Bcl-2 expression 
throughout the menstrual cycle (Compel et al., 1994; Otsuki et al., 1994; Koh 
et al., 1995; McLaren et al., 1997). It is possible that the expression of 
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apoptosis-related proteins is regulated by sex steroids (Otsuki et al., 1994). In 
this context, Critchley et al. (Critchley et al., 1999) reported an increase in 
immunostaining for Bcl-2 protein in glandular and surface epithelium of 
antiprogestin treated endometrium. These data indicate that the expression of 
this gene may be stimulated by estrogen and down regulated by progesterone. 
Bcl-2 immuno-positive cells have also been identified in non-pregnant 
endometrial stroma and in glandular epithelium (Koh et al., 1995; Tabibzadeh 
et al., 1995). It's already reported that both stromal and glandular bcl-2 
concentrations are elevated during the late luteal phase but decreased when the 
luteal phase is extended with exogenous human chorionic gonadotrophin (Koh 
et al., 1995). In the stroma, bcl-2 was immunolocalized to CD56+ large 
granular lymphocytes which comprise the predominant leukocyte population in 
late secretory endometrium (Loke and King, 1995). These cells also 
predominate in first trimester decidua but an association with bcl-2 has not 
been reported previously. The possible regulatory role for apoptosis during 
implantation and early pregnancy suggests that the disturbed regulation of 
apoptosis may be associated directly or indirectly with pregnancy failure. 
Elevated levels of bci-2 can provide resistance to cell death (DiGiuseppe 
et al., 1996; Reed 1997). Bcl-2 has been considered to inhibit apoptosis in the 
human endometrium during the proliferative phase (Otsuki et al., 1994). 
Meresman et al. (2000) reported an increased expression of bcl-2 protein in the 
proliferative eutopic endometrium from women with endometriosis when 
compared with the normal controls. 
2.6. Scanning Electron Microscopy (SEM) imaging of DETS. 
The scanning electron microscope (SEM) is a type of electron 
microscope that images the sample surface by scanning it with a high-energy 
beam of electrons in a raster scan pattern. The electrons interact with the atoms 
that make up the sample producing signals that contain information about the 
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sample's surface topography, composition and other properties such as 
electrical conductivity. 
The SEM imaging study by Kara et al., (2007) on the decidual cells of 
miscarriage and Normal pregnancy showed the presence of higher decidual NK 
cells in the normal pregnancy and a reduction in the number of decidual NK 
cells, and an enhancement in the number of lymphocytes in the miscarriage 
group was observed in their study. The result of this study showed a defective 
immunological milieu interfering in the maintenance of the pregnancy. Susan 
Adams et al., (2004) took certain/relevant tissue characterization criteria for 
surface characterization of the genital uterine tissues making SEM imaging 
results easier to interpret. 
2.7. ROC analysis: An evaluator of test performance. 
The ROC plot, representing the fundamental ability of a test to 
discriminate between two states of health, is an index of pure accuracy. A 
nonparametric ROC plot is an unbiased view of a test's performance (accuracy) 
in a defined clinical setting. The ROC plot itself and ROC analysis provide 
information useful to the clinical researchers in making practical decisions 
about laboratory operation. Furthermore, the ROC plot is a springboard to 
several pathways (Figure 6) to further exploring test performance and for 
clinical application. One convenient global way to quantify the diagnostic 
accuracy of a laboratory test is to express its performance by a single number. 
The most common global measure is the area under the ROC plot. By 
convention, this area is always >0.5 (if it is not, one can reverse the decision 
rule to make it so). Values range between 1.0 (perfect separation of the test 
values of the two groups) and 0.5 (no apparent distributional difference 
between the two groups of test values). The area does not depend only on a 
particular portion of the plot such as the point closest to the diagonal or the 
sensitivity at 90% specificity, but on the entire plot. [Centor and Schwartz 
(1985); Mc Clish (1989); Zweig and Campbell, (1993)] 
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This is a quantitative, descriptive expression of how close the ROC plot 
is to the perfect one (area = 1.0). The statistician readily recognizes the ROC 
area as the Mann-Whitney version of the nonparametric two-sample statistic 
(Bamber, 1975; Hanky and McNeil, 1982), introduced by the chemist Frank 
Wilcoxon. An area of 0.8, for example, means that a randomly selected 
individual from the diseased group has a laboratory test value larger than that 
for a randomly chosen individual from the non diseased group 80% of the time. 
It does not mean that a positive result occurs with probability 0,80 nor it means 
that a positive result is associated with disease 80% of the time. When there are 
no ties between the diseased and non-diseased groups, this area is easily 
computed from the plot as the sum of the rectangles under this graph. 
Analytical formulas to calculate the area are in reports by Bamber (1975) and 
Hanley and McNeil (1982). Alternatively, the area can be obtained indirectly 
from the Wilcoxon rank-sum statistic (Hollander and Wolfe, 1973). Also, the 
area is related to the overlap index of Hartz (1984) by the formula area = I -
(overlap index/2). The area is an unbiased estimate of the true area under the 
theoretical ROC curve. 
It is possible to evaluate whether the test is at all effective in 
distinguishing the two populations as well as to estimate the ROC area by a 
confidence interval. In particular, the rejection of the hypothesis that the 
theoretical area is 0.5 provides evidence that the laboratory test does have the 
ability to distinguish between the two groups. [Zweig and Campbell, 1993] 
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Figure 6: Diagram showing central position of ROC plots in test performance 
evaluation. [Zweig and Campbell, 1993] 
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2.1.1. Sensitivity and specificity of tlie tests 
The sensitivity refers to the true positive fraction of samples i.e., the 
higher the sensitivity the more positive true fractions are present. Whereas, 
Specificity is the measure of false positive fraction and 1-specificity is the 
measure of true negative values of the test. In a much simpler way we can say a 
value to be more of a prognostic/diagnostic use if it comprises of higher 
sensitivity and lower specificity, showing the true negative values to be higher 
and the true positive values to be higher as well. Also is evident that a lower 
sensitivity and higher specificity demonsfrates more false positive values juid 
less true positive values of the test performed leadmg to an insignificant data 
with no diagnostic use. 
2.7.2. Statistical Comparison of Multiple Tests by Use of ROC Plots 
Direct statistical comparison of multiple tests is frequent in clinical 
laboratories. Two (or more) tests are usually performed on the same subjects, 
as in a split-sample comparison. In such cases, the results from two tests are 
usually correlated or associated. It is also possible, but less common; to have 
different individuals for the two tests, in which case the test results are 
independent (and hence uncorrelated). Of these two designs, the paired (split) 
design using the same individuals for the two tests is more efficient and also 
controls the patient-to patient variation. For example, it may be possible to 
detect a real difference by examining 50 individuals with test A and another 50 
with test B, whereas only 40 patients given both tests might have been 
sufficient. When comparison of test performance is accomplished statistically 
by using ROC plots or curves, it is referred to as ROC analysis. ROC graphs 
for the two diagnostic tests, either nonparametric or parametric, can differ in 
shape but still may agree at a single point or have the same areas. Therefore, it 
is always advisable to visualize the entire performances through the ROC 
graphs. Note that with only a single (specificity, sensitivity) pair for each test 
(i.e., only one point on the ROC plot for each test), a comparison of the 
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performance of the two tests is usually impossible. Only if the two points (one 
for each test) are on the same vertical or same horizontal line on the 
nonparametric ROC plot can they be compared (i.e., at a common sensitivity or 
specificity). The statistical analysis was carried on through the SPSS 16 
software for plotting ROC curve and T-test and the results were reconfirmed 
through Sigma Plot 10. 
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Aim: 
The aim of the study is to identify the molecular alterations for the 
management of unexplained recurrent spontaneous abortions (URSA). 
Hypothesis: 
Methylation of gene p53 is implicated in the etio-pathogenesis of 
unexplained recurrent spontaneous abortions (URSA) during early pregnancy. 
To test the hypothesis, present study has been designed to investigate the 
methylation status of gene p53 and its expression along with the expression 
analysis of methylation-related molecules (DNMTl and G9aMT) and apoptosis 
related molecules (Bcl-2 and Bax) in the decidual/ endometrial tissue (DET) of 
normal early pregnancy (NEP) and in the cases of URSA in Indian human 
populations. 
Objectives: 
The study of DET of NEP and URSA have been undertaken 
1) To analyze the methylation status of gene p53 through MSP. 
2) To analyze the apoptotic status through Tunnel Assay. 
3) To analyze the expression level of Bax, Bcl-2, p53, DNMTl and 
G9aMT 
a. At the transcript level through RT-PCR. 
b. At the protein level through IHC and its validation through WB. 
4) For surface characterization through SEM imaging 
5) For statistical analysis of the aforesaid test results through ROC curve 
analysis and student's T-test. 
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HationaCe of Study 
The logic behind conducting this study is to help for the development of 
a long awaited laboratory test to confirm the diagnosis and to provide help in 
the management of the cases of unexplained recurrent spontaneous abortion 
(URSA). 
The extensive search of literatures helps in designing the hypothesis that 
the epigenetic factor of methylation of gene p53 plays a pivotal role in etio-
pathogenesis of URSA. 
To test this hypothesis in view of the existing work done by the earlier 
workers in this field, we have rationally selected to test the methylation status 
of gene p53 by Methylation-specific PCR (MSP), apoptosis by TUNEL assay 
and also performed reverse transcriptase PCR (RT-PCR), 
Immunohistochemical analysis (IHC) and western blotting (WB) for expression 
analysis of G9aMT, DNMTl, Bax, p53 and Bcl-2. 
The surface characterization of the decidual endometrial tissue (DET) 
througji scanning electron microscopy (SEM) also showed encouraging results 
which could advantageously be utilized for differentiating normal early 
pregnancies (NEP) and URSA. 
The results of these tests showed statistically significant aherations 
confirming our hypothesis that methylation of p53 is found to be associated 
with expectedly altered levels of other genes along with the presence of 
apoptosis which could advantageously be utilized to develop a diagnostic kit 
for the cases of URSA. 
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MATERIALS 
5.1 General Chemicals 
Triton X-100, HEPES (pH 7.4), NaCl, EGTA, EDTA, Tris, Ammonium 
Per Sulfate (APS), Sodium Dodecyl Sulfate (SDS), TEMED, Acrylamide, 
Bisacrylamide, 6-Mercaptoethanol, glycerol, bromophenol blue, Coomassie 
brilliant blue, methanol, skimmed milk. Bovine serum albumin (BSA), 3,3'-
Diaminobenzidene (DAB) (Sigma), hydrogen peroxide, DNA and RNA 
loading dye. Agarose, TRIZOL, Diethyl Pyrocarbonate (DEPC), Double 
Distilled Water (DDW), single strength PCR buffer, 2.5 mmol/L 
deoxynucleotide triphosphates, 5 mmol/L random hexamer primer, 1.5 mmol/L 
MgCb, and 200 U Moloney murine leukemia virus reverse transcriptase, and 
Taq DNA polymerase (2.5 U), Hematoxylin, eosin, Poly-L-Lysine, Proteinase 
K, DNase, potassium chloride (KCI), sodium chloride (NaCl), Disodium 
hydrogen phosphate (Na2HP04), Hydrogen chloride (HCl), MOPS, Sodium 
acetate, formamide, formaldehyde, ethidium bromide. Protease inhibitor 
cocktail and Glacial acetic acid. 
5.2 Primers 
Primers used were synthesized by IDT (Integrated DNA technology), 
USA. 
5.3 Blotting membranes 
Polyvinyl pyrolidone difluoride (PVDF) membranes were purchased 
from Millipore, Billerica, MA and MDI Ambala Cantt. India. 
5.4 Plastic ware and glass ware 
PCR tubes and pipette tips were purchased from Axygen (Delhi, India); 
microfiige tubes, falcon tubes were purchased from Larsons as well as Axygen. 
All the laboratory glasswares were purchased from Borosil (Mumbai, India). 
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5.5 Antibodies 
The antibodies used for our study work are rabbit antihuman Bcl-2 
polyclonal antibody (B.D. Biosciences), rabbit antihuman Bax polyclonal 
antibody (B.D. Biosciences), rabbit antihuman p53 polyclonal antibody (B.D. 
Biosciences), goat antihuman DNMTl polyclonal antibody (B.D. Biosciences), 
rabbit antihuman G9a Methyl transferase antibody (Sigma). 
5.6 Equipments used: 
PCR machine, SDS PAGE vertical gel apparatus, horizontal gel 
apparatus, Western blot transfer apparatus, spectrophotometer (UV-Vis), 
Centrifuge, homogenizer, mortar & pestle, horizontal gel running apparatus, 
laminar hood, -80°C cooling refrigerator, -20°C cooling refrigeration, simple 
4°C and 0°C refrigerator, ice making machine,shaker, vortex and water bath. 
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METHODS 
5.7 CLINICAL SPECIMEN 
5.7.1 Sample ColLection 
We have collected fresh decidual/endometrial tissue (DET) samples 
from the subjects of I2normal early pregnancy (NEP) and 15 unexplamed 
recurrent spontaneous abortions (URSA) (3 primary and 12 secondary aborters) 
(Table II) and divided the sample into two, first part was directly kept in an 
autoclaved vial, sealed and dipped in liquid nitrogen during transportation, this 
snap frozen sample had been stored at -SOX for RNA [reverse transcriptase 
polymerase chain reaction(RT-PCR)] and protein analysis [western blotting 
(WB)]. The second part of the saline washed collected specimen of DET was 
kept in vial containing 10% formalin stored at room temperature (RT) for 
histopathological (HP), Immunohistochemical analysis (IHC) and scanning 
electron microscopy (SEM) analysis. All the samples were collected from 
admitted patients of the hospitals with prior permissions from the concerned 
authorities and after obtaining a written informed consent from the individual 
subjects for conducting these tests. 
5.7.2 Ethical Considerations: 
All the samples were collected after written informed consent, from each 
voluntarily agreeing subjects to allow the required tissue analysis for RT-PCR, 
IHC, WB and SEM, as per ethical norms. However the required samples from 
the subjects were normally collected as a part of the mandatory surgical 
procedure of dilatation and curettage (D&C). Though the hospital always takes 
informed consent for the surgical procedures and collection of samples for their 
analysis as a routine from each subject, we have taken additional informed 
consent in writing to allow the required analysis of their samples for the study 
under report. The mandatory permission for collection of the samples has also 
been taken in writing from the authorities of the concerned hospitals. 
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5.7.3 Inclusion and exclusion criteria for sample collection 
• Inclusion-Exclusion Criteria 
The surgical evacuation of decidual/embryonic tissues from the uterus 
were obtained using a Novak curette from both NEP as well as URSA 
by taking into consideration certain inclusion-exclusion criteria for the 
undertaken study as is described below. (Tabulated form is displayed as 
Appendix II) 
> General Inclusion-Exclusion criteria for NEP and URSA: 
The subjects were included if all were "No". 
The subjects were excluded if anyone was "Yes". 
a. Subjects of ages less than 20 yrs or more than 30 years. 
b. Subjects positive for HIV antibody. 
c. Subjects suffering/with symptom of urogenital infection. 
d. Subjects suffering from menstrual/hormonal irregularities. 
e. Subjects associated with congenital/ traumatic/ anatomical 
abnormalities, malnutrition or with other diseases like 
Tuberculosis/diabetics/hypertension/typhoid/pyrexia of unknown origin 
(PUO). 
f Unwanted uterine pregnancy because of failure of oral or injectable 
contraceptives (Hormonal-contraception). 
g. Subjects who have attempted any other means of abortion. 
h. Subjects undergoing surgical abortions (D&C procedure) for uterine 
pregnancy of more than 12* week duration. 
i. Subjects who had developed any significant disease, such as pre-
eclampsia, eclampsia, hydatidiform mole (HM), endometriosis or having 
history of drug intake such as prostaglandin, acetyl salicylic acid and 
antibiotics. 
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> Specific Inclusion-Exclusion criteria for NEP: 
The subjects were included if all were "Yes". 
The subjects were excluded if anyone was "No". 
a. Subjects with unwanted uterine pregnancy (under MTP act) may 
or may not be due to failure of contraception devices like condom 
and lUD. 
b. Early pregnancy not manifested as threatened/inevitable or 
incomplete abortion. 
> Specific Inclusion-Exclusion criteria for URSA: 
The subjects were included if all were "Yes". 
The subjects were excluded if anyone was "No". 
a. Subjects undergoing dilatation & curettage (D«&C) due to 
inevitable/ incomplete abortion of less than 24 hours duration 
for uterine pregnancies of up to 12 weeks without visible 
evidence of any embryonic abnormality (like hydatidiform 
moles, etc). 
b. Subjects having history of two or more such types of 
consecutive recurrent spontaneous abortions. 
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5.7.4 Sample Accountancy 
SAMPLE ACCOUNTANCY 
52NEP ^ _^ _ ^ 
- ^ 
73 RSA-EP 
total of 125 sample collected from Indian females as per 
inclusion-exclusion criteria. 
1 
43NEP 56 RSA-EP 
Samples left after excluding the cases whose consent form was 
missing and improperly collected samples (due to leakage of 
liquid nitrogen/formalin from container). 
J_ 
27NEP 32RSA-EP 
Samples left after excluding the Destroyed Degraded samples 
during transport cases with missing Sample labels. 
V^ 
18 NEP 
k 
23RSA-EP 
Samples left aft^ exclusion of degraded samples during storage 
due to mishandling power failmres. 
T! 
12 NEP 15RSA-EP 
Samples left after excluding the samples which could not be 
satisfactorily analyzed or Processed due to machinery and man 
power problem 
< ^ 
» » * 
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Table II 
Details of Collected Samples 
Sample 
No. of 
Subject 
Nl 
N2 
N3 
N4 
N5 
N6 
N7 
N8 
N9 
NIO 
Ni l 
N12 
R13 
R14 
R15 
R16 
R17 
R18 
R19 
R20 
R21 
R22 
R23 
R24 
R25 
R26 
R27 
Age of 
Subject 
26 
22 
20 
29 
28 
22 
28 
25 
28 
30 
22 
23 
27 
30 
30 
23 
29 
28 
25 
28 
28 
20 
25 
22 
30 
22 
21 
No. of 
Live 
Birth 
2 
0 
0 
2 
0 
3 
2 
3 
3 
1 
0 
1 
0 
0 
2 
1 
1 
2 
2 
1 
2 
1 
1 
2 
3 
0 
2 
No. of 
Previous 
Spontaneous 
Abortic 
A) or 
(Nl 
RSA 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
2 
4 
4 
2 
2 
3 
2 
2 
2 
2 
3 
2 
2 
2 
2 
)n(URS 
MTP 
EP) 
NEP 
0 
1 
0 
0 
0 
0 
0 
0 
0 
0 
1 
1 
0 
0 
0 
0 
0 
1 
0 
0 
0 
0 
1 
0 
0 
1 
0 
Duration 
of Present 
Pregnancy 
(in weeks) 
4 
9 
12 
4 
9 
11 
9 
6 
10 
8 
8 
4 
6 
12 
6 
10 
8 
6 
8 
8 
6 
12 
6 
10 
6 
10 
12 
Surgical abortion by 
D&C for 
NEP 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
URSA 
Incom-
plete 
/ 
/ 
/ 
/ 
/ 
/ 
Inevi 
table 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
Abbreviations: N-NEP sample; R-URSA sample 
Note: A copy of form for informed consent is displayed as Appendix 1 
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S.SMethylation specific PCR (MSP) 
5.8.1 DNA isolation for MSP 
For MSP first the genomic DNA Isolation was carried out as follows: 
Isolation of genomic DNA from human endometrial/decidual tissues was 
carried out using standard protocols by phenol/chloroform method (Blin and 
Stafford, 1976). 
Reagents 
1. Lysis buffer 
a. Tris-HCl (pH 7.5) IM, (working concentration lOmM) 
b. IM EDTA, (working concentration lOmM) 
c. 4M NaCl, (working concentration 50mM) 
2. Proteinase K (lOmg/ml), working concentration lOO i^g/ml 
3. 10%SDS 
4. Equilibrated phenol (equilibrate phenol with IM Tris Ph 7.5) 
5. Chloroform: Isoamyl alcohol (24:1) 
6. 70% Ethanol in DDW 
7. Absolute ethanol 
8. TE buffer 
lOmM Tris (pH 7.5) 
ImM EDTA 
9. Tris Borate EDTA (TBE) 
Fori OX (5L) 
545g Tris 
278g Boric acid 
46.5g EDTA 
10. 6X Gel loading buffer 
0.25% (w/v) bromophenol blue 
0.25% (w/v) xylene cyanol FF 
30% (v/v) glycerol in DDW 
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Procedure 
Tissue (100-300mg) was washed with IX PBS (pH 7.4) to remove the 
blood and cut into small pieces and prepare a single cell suspension by mincing 
tissue pieces over the mesh or homogenized to make single cell suspension. 
Cells were pelleted at 500g for 10 min, cells obtained after homogenization 
were lysed in SOOul of lysis buffer at 37°C for 30 min followed by proteinase K 
(final cone. lOO^g/ml) and 10% SDS (final concentration 1%) at 37°C 
overnight for complete digestion. To the cell lysate added equal volume of 
equilibrated phenol, mixed and centrifuged at 5000g for lOmin at 4°C. 
Transferred the aqueous phase (upper layer containing DNA to a new tube and 
added equal volume of chloroform: Isoamyl alcohol (24:1), mixed gently and 
centrifiiged at 12,000g at 4°C for lOmin. DNA was precipitated from the 
aqueous phase by adding double the volume of chilled absolute ethanol 
followed by centrifugation at 12,000g for 15min. DNA precipitate was washed 
with 70% ethanol, dried and dissolved in TE buffer (50^1). 
5.8.2Preparatioii of agarose gel 
0.8% agarose gel was prepared in 0.5X TBE with EtBr solution added to 
give a final concentration of S i^g/ml. A comb was inserted into the apparatus to 
form the wells, and the gel was left to solidify. The comb was removed once 
the gel has been set and the gel plate support was placed into the running 
apparatus filled with 0.5X running buffer to just cover the wells. DNA samples 
were prepared by addition of 6X gel loading dye and loaded into the wells of 
the gel. The gel was run at a constant voltage of 60V for l-3h and the DNA 
was viewed on a UV transilluminator. 
5.8.3 Determination of DNA Methylation 
• Bisulphite Modification 
Bisulphite modification of the DNA involves chemical modification of 
cytosine to uracil by bisulphate treatment (Frommer et al., 1992), but 
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those that are methylated (5-methylcytosine) are resistant to this 
modification and remain as cytosine (Wang et al., 1998). 
• Denaturation 
1 jig of DNA was diluted in 50fil of distilled water. Then DNA was 
denatured by adding 5.5^1 of 2M NaOH (final concentration, 0,2M) at 
37°C for lOmin. 
• Deamination 
30^1 of 10 mM hydroquinone and 520nl of 3M sodium bisulphate (pH 
5.0) were added and mixed (both the solutions were freshly prepared) to 
denature the DNA. Then the samples were incubated under mineral oil 
at 50°C for 16h in dark. 
• Desulphonation 
After overnight incubation DNA was purified using Wizard DNA 
purification resin according to the manufacturer's instructions 
(Promega). In brief, 1ml of resin was added to the DNA solution and it 
was mixed well. This was then passed through the column. The column 
was washed with 2ml 80% isopropanol and DNA was eluted into 50^1 
of water. Desulphonation was carried out by adding 5.5jil of 3M NaOH 
(final concentration, 0.3M) for 5min at room temperature. 
• Neutralization and desalting 
After desulphonation, the DNA was neutralized by adding 33^1 of lOM 
ammonium acetate, l|il glycogen was added as a carrier, and 150|J,1 (3 
volumes) of absolute ethanol was added to precipitate the DNA at -20°C 
overnight. DNA precipitate was recovered by centriftigation at 12,000g 
for 30min. Then DNA was washed with 1ml of 70% ethanol, air dried 
and dissolved in 20^1 of ImM Tris (pH 8.0) at 65X for lOmin and 
stored at -20 T . 
Bisulphite treated genome DNA was analyzed by MSP using a primer specific 
for methylated and unmethylated DNA as given in table III for particular genes 
were given the PCR conditions as given in table IV. The PCR samples were 
resolved by electrophoresis in a 2% agarose gel and stained with ethidium 
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bromide. Negative control were taken in which the template i.e., bisulphate 
treated DNA was not added. The genomic DNA from human DETS with 
normal pregnancy was treated as positive control. 
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Table III 
Details of gene specific primer sequences for MSP-Analysis 
Gene 
P53(U) 
P53(M) 
Primer Sequence 
5'- TTG GTA GGT GGA TTA TTT GTT T -3 ' 
5'- CCA ATC CAA AAA AAC ATA TCA C -3 ' 
5'-TTC GGT AGG CGG ATT ATT TG-3' 
5'-AAA TAT CCC CGA AAC CCA AC-3' 
Product 
length (bp) 
247 
243 
Table IV 
PCR details of primers for MSP-Analysis. 
Name 
Of the 
gene 
P53 
(U) 
P53 
(M) 
Initial 
Denaturat 
-ion 
95°C;5min 
80°C;3min 
95°C;5min 
80°C;3min 
Denatu ration 
95°C, 30 sec 
95°C, 30 sec 
Annealing 
58°C;30sec 
60°C;30sec 
Extension 
72°C;30sec 
72°C;30sec 
Cycles 
35 
35 
Final 
Extension 
72°C;5min 
72°C;5miii 
Termination 
4°C;12hr 
4°C;12hr 
1 
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5.9 TUNNEL ASSAY 
TUNEL assay was carried out essentially as described previously (Baldi 
et al. 2000), After removal of paraffin with xylene and rehydration in ethanol 
solutions of decreasing concentrations, sections were digested for 10 min with 
proteinase K (20 mg/ml), washed in distilled water, and exposed briefly to 3% 
H2O2 to inactivate endogenous peroxidase. The TUNEL reaction was 
performed using the peroxidase-based Apoptag kit (Oncor). TUNEL positive 
cells were detected with diaminobenzidine (DAB) and H2O2 according to the 
supplier's instructions. Finally, stained sections were lightly counterstained 
with haematoxylin. Cells were defined as apoptotic if they were TUNEL-
positive. This experiment was repeated on several different sections for each 
specimen, obtaining similar results. 
The number of apoptotic cells were categorized as (-), <3 apoptotic 
cells/field; (+), 3-8 apoptotic cells/field; (++), >8 apoptotic cells/field, at x 630 
magnification with use of an arbitrary scoring system comparable with that 
used by Watanabe et al. (1997). 
5.10 RT-PCR Analysis 
For RT-PCR first the RNA isolation was performed followed by cDNA 
synthesis as described in the section below. 
Reagents 
. Trizol : 7^??V/ -
• RNaseAWAY 
• Chloroform 
• Isopropanol (Ice chilled) 
• DEPC treated DW 
• Formaldehyde gel-sample loading buffer dye: 
50% glycerol 
lmMEDTA(pH8.0) 
0.25% Bromophenol Blue (BPB) 
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0.25% Xylene Cyanol FF 
• 5X Formaldehyde gel-running buffer: 
O.IM MOPS (pH 7.0) 
40mM Sodium Acetate. 
5mM EDTA (pH 8.0) 
5.10.1 RNA ISOLATION FROM DET OF NEP AND URSA for RT-PCR. 
The following steps were carried out for RNA isolation: 
1. Prepared tissue homogenizer by washing with RNAse AWAY, followed 
by rinsing several times with water. RNA is protected from RNAse 
activity in TRIZOL. 
2. Measure tissue into a polypropylene 15 ml test tube. 
3. Added 2 ml TRIZOL per approx. 100 mg tissue. 
4. Grind tissue at approx. 70 percent power for 30 seconds to one minute. 
Tissue grinded till fine suspension obtained. 
5. Let cells lyse in Trizol for 5 minutes at room temperature. 
6. Add 200^1 chloroform to each microfuge tube. 
7. Gently invert tube approx 20 times to emulsify Trizol and chloroform. 
Mixture should become somewhat milky. Avoid shaking which shears 
genomic DNA (which would then contaminate the RNA isolated). 
8. Incubate at room temperature for 3 to 15 minutes. 
9. Spin samples at 12000g for 15 minutes at 4 °C. Should have three 
phases. The top layer is clear and colorless and contains RNA. 
Sometimes this layer has a faint pink color but this does not seem to 
affect the final performance of the RNA. The interface is white and not 
very stable. Handle tubes gently! The proteins and DNA reside in this 
layer and the pink bottom layer. 
10. Removed the top layer (aqueous layer) to a fresh microfuge tube. Be 
very careful not to disturb the interface. It is best to leave a significant 
portion of the top layer behind (maybe 20%). Often, RNAse 
contamination in samples is the result of carryover of interface layer. 
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11. Add 500 |il cold isopropanol (per ml of TRIZOL originally used) to 
precipitate RNA. 
12. Mix well. 
13. Wash pellet 2 times with 75% ethanol (ice-cold). Spin samples for 10 
minutes, 7500g, 4°C. 
14.Resuspend RNA pellet in 12.5 i^l DEPC-dH20. Place open tube on 
heating block at 55°C for 10 minutes, to evaporate any residual ethanol. 
15. Close cap and cool. 
16. Measure volume in tube and restore to 12.5 jil. 
17. DNAse treatment. 
To remove traces of DNA remained in the RNA, total RNA was treated 
with DNase I by the following method. 
2^1 RNA 
2^1 lOX DNase I Reaction Buffer 
2nlDNaseI, lU/^il 
14}il DEPC-treated water 
The above reaction mixture was incubated at 37°C for 15minutes. 
DNase I was inactivated by adding 5|il of 25mM EDTA solution to the 
reaction mixture and then heating at 65°C for 10 minutes. 
18. Inactivate DNAse by addition of 5 ^1 inactivation reagent. Flick and let 
sit at room temp with occasional flicking for two minutes. 
19. Spin out the inactivation reagent, 10,000 g, 1 min. Remove top layer 
(which contains RNA), to a fresh 0.5 ml microfuge tube. Split the 
recovered material between two 0.5 ml microfuge tubes. Label well and 
store at -80°C. Use one tube up before thawing the second tube. 
20. Check quality of RNA spectrophotometrically and on a denaturing 
formaldehyde gel. 
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5.10.2 Denaturing gel electrophoresis of RNA- Formaldehyde gel 
The gel was prepared by melting the appropriate amount of agarose in 
water and heated to 60° C and added 5x formaldehyde gel-running buffer to 
give final concentrations of IX and 15% formaldehyde. The gel was casted in a 
fume hood, and allowed to set for atleast 30 mins at RT. 
Sample preparation: 
• RNA (up to 30ng) 4.5jil 
• 5 X formaldehyde gel-running buffer 2.0^1 
• Formaldehyde S.Sjil 
• Formamide 10.0|iil 
Samples were heat denatured at 65 °C for 15minutes to remove secondary 
structures, chilled immediately on ice and loaded on the gel by mixing with 2^1 
of sterile, DEPC-treated formaldehyde gel-loading buffer, immediately after 
heat denaturation. 
Before loading the samples, the gel was pre-run for 5 minutes at 5 V/cm. The 
gel was electrophoresed in Ixformaldehyde gel-running buffer at 3-4 V/cm. At 
the end of the run the gel was stained with ethidium bromide (i.e., 0.5 ng/ml 
dissolved in 0.1 M Ammonium acetate) for 30-45 minutes. 
28S and 18S rRNA markers were also loaded along with the samples in 
a well at one end of the gel. The stained gel was seen under UV 
transilluminator, measured the distance from the well to the two bands: 18S 
RNA is 1.4kb and 28S RNA is 4.8kb. 
5.10.3 cDNA synthesis 
For cDNA analysis, RT-PCR was performed as reported previously 
(Sugino et al, 1998) with the oligonucleotide primers (as given in table V) for 
Bcl-2 and Bax, designed by Hori et al., (1997) and Kugu et al. (1998), 
respectively, DNMTl, G9a, p53 direct sequence analyses of the PCR products 
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were performed for sequence verification. Two oligonucleotide primers were 
also used to amplify housekeeping gene P-actin. In brief, 3 mg total RNA were 
reverse transcribed at 42°C in a reaction mixture (single strength PCR buffer, 
2.5 mmol/L deoxynucleotide triphosphates (dNTPs), 5 mmol/L random 
hexamer primer, 1.5 mmol/L MgCb, and 200 U Moloney murine leukemia 
virus reverse transcriptase). The RT product was divided into equal aliquots 
and placed into seven tubes with Bcl-2 (or Bax or DNMTl or p53 or G9a or 
Beta actin) primers, and PCR was performed. For PCR amplification, a mixture 
containing the oligonucleotide primers (50 pmol), and Taq DNA polymerase 
(2.5 U) was added to each reaction. Amplification was carried out for 35 cycles 
as described in table VI. The predicted sizes of the PCR-amplified products 
(cDNA) were obtained. To separate the band of Bcl-2/ Bax/ DNMTl/ G9a/ p53 
and P-actin, reaction products were electrophoresed on polyacrylamide non-
denaturing gel under 200 V for 2 h. After staining with ethidium bromide, band 
intensities were quantified with Chemi Imager IS-4400 (Alpha Innotech Corp., 
San Leandro, CA). The intensities of individual PCR product bands of 
DNMTl, G9a, p53, Bcl-2 and Bax were first normalized by dividing their 
intensities by the intensities of their corresponding P-actin bands. These 
normalized intensities of the corresponding PCR product bands from the DETS 
of normal and URSA cases were then divided by the normalized intensities of 
the corresponding PCR product bands from the normal patient DETS to obtain 
fold changes of mRNA levels in tissues. Statistical analysis was carried out by 
independent t-test with the SPSS software (version 9.01, SPSS, Chicago). 
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Table V 
Details of gene specific primer sequences 
Gene 
DNMTl 
Bcl-2 
Bax 
G9a 
p53 
Beta-
actin 
Primer Combination 
5'-TAC CTG GAC CCT GAC CTC-3'; 
5'-CGT TGG CAT CAA AGA TGG ACA-3' 
5'-GAC TTC GCC GAG ATG TCC AG-3'; 
5'-TCA CTT GTG GCT CAG ATA GG-3' 
5'-GGT TTC ATC CAG GAT CGA GAC GG-3'; 
5'-ACA AAG ATG GTC ACG GTC TGC C-3' 
5' -GAG GTG TAC TGC ATA GAT GCC-3'; 
5'-CAG ACG GCT CTG CTC CAG GGC-3' 
5'- GGC CCA CTT CAC CGT ACT AA -3 ' 
5'- GTG GTT TCA AGG CCA GAT GT -3 ' 
5'-CAG CCA TGT ACG TTG CTA TCC AG-3'; 
5'-GTT TCG TGG ATG CCA CAG GAC-3' 
Product 
length (bp) 
335 
390 
445 
285 
156 
421 
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Table VI 
RT-PCR details of primers 
Name 
Of the 
Gene 
DNMTl 
P53 
Bcl-2 
Bax 
G9aMT 
P-actin 
Initial 
Denaturati 
on 
94°C;5min 
94°C;5mm 
94°C;5min 
94°C;5min 
94°C;5min 
94°C;5min 
Denaturation 
94°C, 30 sec 
95°C, 30 sec 
94T, 30 sec 
94°C, 30 sec 
94°C, 30 sec 
94T, 30 sec 
Annealing 
55'C;30 
sec 
60°C;30 
sec 
56°C;30 
sec 
59°C;30 
sec 
64°C;30 
sec 
62°C;30 
sec 
Extension 
72°C;30 
sec 
72°C;30 
sec 
72°C;30 
sec 
72X;30 
sec 
72°C;30 
sec 
72°C;30 
sec 
Cycles 
35 
35 
35 
35 
35 
35 
Final 
extension 
72°C;5 
min 
72°C;5 
min 
72°C;5 
min 
72°C;5 
min 
72°C;5 
min 
72°C;5 
min 
Termination 
4°C;12hr 
4°C;12hr 
4°C;12hr 
4°C;12hr 
4°C;12hr 
4T;12hr 
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5.11 Immunohistocheinical studies 
5.11.1 Hematoxylin and Eosin staining 
Tissue fixed in 10% buffered fonnalin was mounted in paraffin for 
preparation of tissue blocks. Sections (5^m thickness) of tissue specimens were 
cut using a microtome. The sections were deparaffinized by dipping in xylene 
for 10 min. and then fixed by sequential dipping in acetone for 10 min, absolute 
ethanol for 1 min followed by washing under slow water for 3 min. Washed 
sections were dipped in hematoxylin for 1 min which stained the nucleus. 
Excess stain was washed off by dipping the slide in 1% acid-alcohol and then 
keeping these under slow running water for 2-4 min. The slides were examined 
under light microscope for any excess staining. If there was non-uniform 
staining in any section it was re-dipped in 1% acid-alcohol and washed 
properly under slow running water. Slides were subsequentially dipped in 
Eosin (30%, 50%, 70% and 90%) to stain the cytoplasm. Thereafter, the slides 
were washed with acetone and finally with different grades of alcohol (70%, 
95%). After 95% alcohol washing, the slides were dipped in xylene for 2 min. 
Slides were then dried and mounted with DPX mountant, viewed under a light 
microscope and photographed. Serial sections were used for immunostaining as 
described below. 
5.11.2 Immunohistochemical analysis of selected molecules under study. 
Paraffin embedded sections (5fim) of human endometrial/decidual 
normal and URSA tissue collected on gelatin/Poly-L-Lysine coated slides. The 
sections were deparaffinized in xylene, hydrated in graded alcohol and 
incubated with Hydrogen peroxide (0.3% v/v) in methanol for 20 min to 
quench the endogenous peroxidase activity 0.3% (v/v) H2O2 in methanol for 30 
min. to inactivate the endogenous peroxidases. Slides were washed with Tris 
Buffer saline (TBS, O.IM, pH 7.4) and pretreated in a microwave oven in 
citrate buffer [0.01 M (pH 6.0)] for antigen retrieval. Non-specific binding was 
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blocked with 1% Bovine Serum Albumin (BSA) in phosphate buffer saline 
(PBS, 0.0IM, pH 7.2) for 1 hour. Thereafter, slides were incubated with 
specific primary antibody for 16 hour at 4°C and washed with PBS. The 
primary antibody was detected using Strep-Avidin-Biotin complex using Dako 
LSAB+kit (Dako CYTOMATION, Glostrup, Denmark) and Diamine 
Benzidine as chromogen. All incubations were performed at room temperature 
in a moist chamber. Slides were washed with Tris-Buffered Saline (TBS, O.IM, 
pH 7.4), three times after every step. Finally the sections were counter stained 
with Mayer's Hematoxylin and mounted with D.P.X mountant. In negative 
controls the primary antibody was replaced by non-immune IgG of the same 
isotype to ensure specificity. 
5.11.3 Positive criterion for immunohistocheniical staining. 
The immuno-positive staining was evaluated in five areas of the tissue 
section. For all these proteins under study, specific staining in decidual cells 
was defined as positive staining. For the selected protein expression sections 
were scored as positive if decidual cells show immuno-positivity in cytoplasm 
and/or plasma membrane and/or nucleus when observed by two independent 
observer who were blinded to clinical outcome that is the slides were coated 
and pathologist did not have prior knowledge of the history of the patient slide 
under study and even was blinded to the differentiation between slides of 
normal pregnancy cases juid that of URSA cases. A semi-quantitative 
assessment method was used, as previously described (Compel et al., 1994; 
Koh et al., 1995). Each observer viewed multiple randomly selected 5 fields of 
each tissue specimen at x 400 magnifications and scored their staining intensity 
by grades. The intensity grade was determined by averaging the scores for all 
the glands observed. The intensity of staining was scored as (-) negative, (+) 
weakly positive, and (++) strongly positive. 
The observers also scored the IHC slides processed under the same 
conditions: score 0 (less than 1% of posifive cells), score 1 (fi-om 1% to 10% of 
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positive cells); score 2 (from 10% to 20% of positive cells); score 3 (more than 
20% of positive cells). The level of concordance, expressed as the percentage 
of agreement between the observers was 89%. In the remaining specimens the 
opinions of the two investigators in agreement were taken in consideration. An 
average of 5 fields was observed for each specimen (M. De Falco et al. 2001). 
All values were expressed as means ± standard error of mean (SEM) and 
differences were compared using Student's t-test (Bliss 1967). 
The advantage of this method is its precise localization of the protein on 
the endometrial/decidual section, while at the same time it enables a correlation 
between the presence of apoptotic cells measured by the TUNEL method and 
Bcl-2/Bax expression. 
5.12 Western Blot analysis 
The WB analysis comprises of three steps the protein extraction, SDS-
PAGE analysis and finally the immunoblot transfer followed by membrane 
development as is discussed in the section below. 
5.12.1 Extraction of proteins 
Biopsy samples of human endometrium or decidua of ~3 mg wet tissue 
were used. In order to avoid the consequence of immunoblotting being 
influenced by the presence of serum proteins, endometrial blood vessels were 
removed mechanically, and biopsy samples were extensively washed with PBS. 
Afterwards the samples were chopped and further washed extensively with 
PBS and homogenized. Tissue proteins were extracted in a buffer solution 
containing 0.5% Triton X-100, 10 mmol/1 HEPES (pH 7.4), 150 mmol/1 NaCI, 
2mmol/l EGTA, and 2 mmol/1 EDTA. After centrifiigation for 20min at 15 000 
g, the concentration of protein in soluble fractions was measured according to a 
published method (Lowry method (1951)). The concentration of total proteins 
for each sample was calculated and took around BO^ ig of protein each for SDS-
PAGE analysis and western blot. (Berkova et al., 2001) 
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5.12.2 SDS PAGE analysis 
Proteins in the soluble fraction of the tissue extracts were separated 
under reducing conditions in 12% sodium dodecyl sulphate-poly aery lamide gel 
electrophoresis (SDS-PAGE) according to a published method (Laemmli, 
1970). The 15 i^l samples containing 30 ng of proteins in 3-fold-concentrated 
Laemmli solution (200 mmol/1 Tris, pH 6.9, 6% SDS, 6% 6-Mercaptoethanol, 
45% glycerol and 0.03% bromophenol blue) were boiled for 10 min before 
being loaded into the well. After electrophoresis, the proteins were stained with 
Coomassie brilliant blue, or silver staining was performed or kept unstained in 
transfer buffer contaming 20% methanol for western blot analysis. 
5.12.3 Immuno-blot transfer 
Thirty micrograms of protein, determined by the Lowry method (1951), for 
G9aMT, Bcl-2, Bax, p53 and DNMTl were separated by SDS-PAGE in 8%, 
10%, 12%, 15% gels under reduced conditions. The proteins in the gel were 
electrophoretically transferred through the WB transfer apparatus to PVDF 
membranes and reacted with the rabbit antihuman Bcl-2 polyclonal antibody 
(B.D. Biosciences) or rabbit antihuman Bax polyclonal antibody (B.D. 
Biosciences) or rabbit antihuman p53 polyclonal antibody (B.D. Biosciences) 
or goat antihuman DNMTl polyclonal antibody or rabbit anti human G9aMT 
(Sigma) at a dilution of 1:50 with 0.5% skimmed milk in Tris buffered saline 
(pH 7.5). The membranes were then immersed in the reaction buffer containing 
peroxidase-conjugated mouse/goat/human anti-rabbit IgG with 0.5% skimmed 
milk. The reacted bands were developed with a hydrogen peroxide and DAB. 
Reacted bands of G9aMT, Bcl-2, p53, DNMTl and Bax were scanned and the 
intensity of the respective protein expression through bands was quantified 
with Chemi Imager IS-4400 (Alpha Innotech Corp., San Leandro, CA). The 
intensities of individual Western blot protein bands were first normalized by 
dividing their intensities by the intensities of their corresponding P-actin bands. 
These normalized intensities of the corresponding protein bands from the 
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DETS of normal and URSA cases were then divided by the normalized 
intensities of the corresponding protem band from the normal patient DETS to 
obtain fold changes of protein levels in tissues. Statistical analysis was carried 
out by independent t-test with the SPSS software (version 9.01, SPSS, 
Chicago). 
5.13 SEM IMAGING 
Tissue preparation for Scanning Electron Microscopy (SEM) 
Sample in 10%formalin was collected and for SEM imaging a piece of 
tissue taken out from the sample mobbed away by blotting papers and then kept 
for 1 hour in an oven at 60° C for 1 hour. This dried piece of tissue was taken 
and lOnm thin gold coatings by gold sputter coater unit was performed and 
then finally the prepared sample was viewed Under a Carl-Zeiss [EVO, MA-10 
an advanced model of SEM (made in UK)] to identify the surface 
morphological characteristics of DETS of URSA and NEP of early pregnancy 
under different magnifications. 
5.14 Statistical Analysis 
Fold change values determining the level of expression in the form of 
[mean (M) + Standard error mean (S)] was calculated with the help of 
SigmaPlot 10.0 along with the respective p-values. 
The RT-PCR, IHC, WB and SEM data was subjected to statistical 
analysis using SPSS 17.0/SigmaPlotlO.O software. Sensitivity and specificity 
was assigned for each gene. Sensitivity is defined as the quotient of True 
Positives (TP) / No of URSA patients (R), i.e., the proportion of the true 
positives that are correctly predicted as being recurrently aborted. Similarly, 
specificity is defined as the quotient of True Negative (TN) / No. of normal 
decidual tissue showing no evidence of URSA (N), i.e., the fraction of true 
negative cases predicted as being normal decidual tissue with no 
histopathological evidence of URSA. The sensitivity and specificity as well as 
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the cut off points of the respective molecules for both the transcripts and 
proteins was quantified using receiver operating characteristic (ROC) curves 
and Independent t test was performed through SigmaPlot 10.0. 
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6.1 Role of Epigenetics in DET of URSA and NEP. 
To understand the role of certain factors we took into consideration the gene p5i 
for studying the epigenetic factor like methyiation and tried to sort its function in 
the cases of URSA-DET. In this prospective study the genomic DNA was isolated 
from all the URSA-DET and NEP-DET by phenol-chloroform method (as already 
described in materials and methods section). A representative agarose gel showing 
the integrity of the genomic DNA isolated from URSA and NEP DET is shown in 
figure 7(a). 
We determined the methyiation status of p5i gene in the samples through 
methyiation specific-PCR (MSP) using bisulfite treated genomic DNA of both 
URSA-DET and NEP-DET cases of human female (as described in materials and 
methods section). 
In tissues, the gene was considered to be methylated if the results of MSP showed 
the presence of amplicons depicted in the form of bands in 2% agarose gel. The 
gene was considered to be methylated if the expression of methylated (M) alone or 
both methylated as well as unmethylated (U) amplicons (heterogeneous 
expression) (U/M) were found to be present in the gel. The expression level of the 
amplicons i.e., both M and U are shown in Table VII representing absence of 
expression by (-) symbol, (+) being designated for low expression and (++) for 
high expression. 
6.1.1. pJi gene methyiation status in URSA-DET and NEP-DET. 
For predicting the methyiation status oipSi gene, the expression of amplicons (M, 
U) was tested in both NEP-DET and URSA-DET. 
91.67% NEP-DET cases showed low expression and rest showed no expression of 
U-p53 when 83.33% cases with high expression of M-p53 was observed in the 
same. Whereas in URSA-DET 73.33% cases showed high expression, 13.33% 
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with no expression and another 13.33% cases with low expression of the U-p53 
whilst the amplicon of M-p53 in the URSA cases showed low expression in 60% 
cases and no expression in 40% cases. 
The above result suggests hypomethylation of p53 leads to high expression of p53 
in URSA-DET and the reverse of it is observed in NEP-DET cases i.e., low 
expression of p53 and high p53 methylation compared to URSA (fig.7(b). Figure 
8, Table VII). 
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Figure 7: (a): Agarose gel image of Genomic DNA isolated from Decidual/ 
endometrial tissue system (DET). Genomic DNA was isolated from 
URSA and NEP tissues by phenol-chloroform method. The isolated 
DNA was run on 0.8% agarose gels and visualized using ethidium 
bromide on a UV transilluminator. N1.4: Normal; R1.4: URSA DET 
DNA. 
(b): Agarose gel result of MSP analysis showing expression of 
methylated and unmethylated p53 in the DET of URSA and NEP. 
Result shows hypomethylation of p53 leads to over expression of 
immethylated p53 in the cases of URSA. While reverse is found in 
normal early pregnancy (NEP). 
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Figure 8: Error bar graph showing the score of methylated and unmethylated 
p53 analyzed through MSP in the DET of both URSA and NEP. 
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Table VII 
Result of MSP-analysis of p53 showing details of expressions in each DET 
Samples along with its [Mean (M)+Standard Error of Mean (S)] 
Samples 
Nl 
N2 
N3 
N4 
N5 
N6 
N7 
N8 
N9 
NIO 
N i l 
N12 
R13 
R14 
R15 
R16 
R17 
R18 
R19 
R20 
R21 
R22 
R23 
R24 
R25 
R26 
R27 
N [M±S] 
R [M±S] 
P value 
p53 
U 
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
++ 
-H-
++ 
++ 
++ 
++ 
+ 
++ 
-H-
++ 
+ 
++ 
-H-
-
-
0.92+0.083 
1.60±0.19 
<0.01 
M 
++ 
++ 
++ 
++ 
++ 
++ 
+ 
+ 
++ 
++ 
++ 
++ 
-
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
-
+ 
-
+ 
-
-
1.83+0.11 
0.60±0.13 
<0.0001 
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6.2. TUNEL ASSAY- AN APOPTOSIS CONFIRMATION TOOL. 
All the normal (NEP) cases were found to be TUNEL negative with a decrease in the number 
of apoptotic cells from 8.46 to 1.75 when compared to the TUNEL positive URSA. The 
result was found to be statistically significant with a p-value<0.001. 
This analysis independently justified as well as confirmed apoptosis to be a factor involved 
in the URSA and hence again proving p53 hypomethylation to be involved in triggering the 
cascadic pathway of apoptosis during URSA. 
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Figure 9: Representative image of TUNEL assay of histological sections of 
DET from NEP and URSA cases showed unstained (NEP) and stained (URSA) 
nuclei confirming apoptosis [Arrows showing nucleus]. 
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TABLE VIII 
Results of TUNEL Assay showing the detailed result of each sample. 
SAMPLES 
Nl 
N2 
N3 
N4 
N5 
N6 
N7 
N8 
N9 
NIO 
Ni l 
N12 
R13 
R14 
R15 
R16 
R17 
R18 
R19 
R20 
R21 
R22 
R23 
R24 
R25 
R26 
R27 
N (M+SJ 
R [M+SI 
P value 
TUNEL assay 
-
+ 
-
-
-
+ 
-
-
-
-
-
-
++ 
++ 
+ 
+ 
++ 
++ 
+ 
++ 
+ 
-
++ 
-H-
++ 
+ 
++ 
1.75±0.55 
8.47±0.84 
<0.001 
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Figure 10: Error-bar graph representing no. of apoptotic cells in the URSA and 
NEP cases. The graph clearly shows an increment of apoptotic cells in the DET 
of URSA as compared to that of NEP. 
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6.3: Molecular expression analysis of a selected panel of genes in the cases of URSA and 
NEP. 
The RT-PCR analysis was done (as described in materials and methods section) to analyze 
the mRNA expression level of apoptosis related genes {BCL-2, BAX and p53) and 
methylation related gQnes(DNMTI and G9aMT) (fig. 11) in DET of both URSA and NEP 
using specific primers (as given in Table IX) to evaluate the effect of molecular expression 
on abortion (URSA) cases. 
6.3.1 Evaluation of panel of genes at transcript level: 
Fifteen URSA cases were analyzed for the expression of mRNA using RT-PCR. In 
URSA, G9aMT mRNA expression showed significant decrease firom 0.61 to 0.34 fold 
where as DNMTl showed 0.65-0.57 fold change as compared to that of control 
(NEP). Of these, 93.3% URSA showed Bcl-2 transcripts, while 91.6% normal tissues 
showed high Bcl2 mRNA (Fig. 11, and 12). RT-PCR analysis of the DET showed 
complete absence or significantly reduced Bcl2-mRNA in URSA as compared to NEP 
cases (p< 0.001). In URSA, Bcl2 level was reduced fi-om 0.66 to 0.27 folds when 
compared to NEP, suggesting that it plays an important role in normal pregnancy 
(fig.ll&12,TableIX). 
Box mRNA (fig.l 1 & 12) with a fold change of 0.23 to 1.06 showed high expression of Bax 
in 93.3% URSA, while low Bax expressions were observed in all the cases of NEP. Also, 
elevation in the fold change value of gene/755 from 1.64-0.69 in URSA cases were observed 
when compared to the controls (NEP) (fig.l 1 & 12, Table IX). 
So G9aMT, Bcl-2 and DNMTl are found to be down regulated, whereas Bax and p53 are 
up-regulated during URSA as compared to NEP during early pregnancy. 
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P53 
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p-actin 
G9a-hAT DNMTl 
Figure 11: Agarose Gel image showing mRNA expression assessed through RT-
PCR. The bands show the expression of the respective mRNA normalized to their 
patient specific P-actin levels and flirther the band intensities were quantified with 
Chemi Imager IS-4400 (Alpha Innotech Corp., San Leandro, CA). 
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Figure 12: Error bar graph of mRNA fold change level of genes analyzed through 
RT-PCR of Bcl-2, Box, G9aMT, DNMTl and p53 in URSA (R) and NEP (N). The 
graph clearly indicates elevated expression level of Bax and p53 and a decreased 
expression level of G9aMT, DNMTl and Bcl-2. 
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TABLE IX 
Result of RT-PCR analysis showing the respective values of band intensities of each NEP 
and URSA cases. 
Samples 
Nl 
N2 
N3 
N4 
N5 
N6 
N7 
N8 
N9 
NIO 
Ni l 
N12 
Rl 
R2 
R3 
R4 
R5 
R6 
R7 
R8 
R9 
RIO 
Rl l 
R12 
R13 
R14 
R15 
N(M+S1 
R[M+S] 
P-value 
FOLD CHANGE/EXPRESSION 
Bcl-2 
0.57 
0.59 
0.63 
0.74 
0.75 
0.62 
0.54 
0.39 
0.55 
0.82 
0.66 
1.00 
0.22 
0.23 
0.39 
0.38 
0.09 
0.25 
0.20 
0.36 
0.16 
0.27 
0.10 
0.43 
0.42 
0.22 
0.26 
0.66±0.05 
0.27±0.03 
<0.001 
Bax 
0.27 
0.36 
0.39 
0.43 
0.25 
0.17 
0.16 
0.08 
0.24 
0.18 
0.10 
0.15 
0.41 
1.50 
1.10 
2.46 
0.84 
1.87 
0.60 
0.88 
1.37 
1.75 
0.73 
0.54 
0.72 
1.00 
0.18 
0.23+0.03 
1.06+0.16 
<0.001 
p53 
0.62 
1.00 
0.88 
0.71 
0.76 
0.71 
0.80 
0.51 
0.58 
0.57 
0.67 
0.50 
1.83 
2.59 
2.23 
1.22 
0.32 
4.22 
1.40 
2.12 
1.05 
2.52 
0.40 
1.05 
1.28 
1.68 
0.74 
0.69+0.04 
1.64+0.26 
0.003 
G9aMT 
0.54 
0.70 
0.92 
0.99 
0.96 
0.67 
1.00 
0.23 
0.30 
0.35 
0.25 
0.45 
0.51 
0.14 
0.33 
0.25 
0.49 
1.02 
0.37 
0.46 
0.14 
0.44 
0.11 
0.23 
0.46 
0.12 
0.09 
0.61+0.09 
0.34+0.06 
0.016 
DNMTl 
1.00 
0.69 
0.73 
0.94 
0.95 
0.60 
0.79 
0.43 
0.41 
0.38 
0.33 
0.54 
0.31 
0.40 
0.43 
0.57 
0.21 
0.67 
0.16 
0.26 
1.76 
0.84 
0.61 
0.18 
1.68 
0.29 
0.12 
0.65+0.07 
0.57+0.13 
0.612 
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6.3.2.1 Evaluation of panel of genes at protein level through IHC: 
The results of immunohistochemical (IHC) analysis of G9aMT, DNMTl, Bcl-2 
and Bax expression in 15 URSA, 12 normal tissues are summarized in Table X. 
6.3.2.1 (a) IHC analysis of Methylation related proteins in N£P and URSA-
DET cases. 
Firstly, hematoxylin and eosin (H&E) staining was performed to confirm the 
histopathology of URSA and NEP. H&E sections showed regions of decidual 
sheet and glandular epithelium demonstrating Arias-Stella reaction (Fig 13 A), 
indicating normal healthy uterine pregnancy, Immunohistochemical analysis of 
G9a methyl transferase (G9a MT) was carried out in 15 URSA cases and their 
histologically matched NEP-DET in the same cohort as we have used for RT-PCR 
analysis. Only the glandular epithelial tissue showed intense cytoplasmic 
immunoreactivity (Fig 13), whereas no detectable immunoreactivity was observed 
in nucleus or membrane of normal tissue (NEP-DET). No immuno-reactivity of 
G9aMT was observed in URSA-DET. 
Significant reduction in G9a MT IHC-score was observed in URSA as compared 
to NEP (p-value <0.001) (Table X, fig 13 &16). 
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TABLE-X 
Result of IHC analysis of DET of NEP and URSA of all the individual 
samples. 
SAMPLE 
S 
Nl 
N2 
N3 
N4 
N5 
N6 
N7 
N8 
N9 
NIO 
Ni l 
N12 
R13 
R14 
R15 
R16 
R17 
R18 
R19 
R20 
R21 
R22 
R23 
R24 
R25 
R26 
R27 
N[M+S1 
R[M+S1 
P value 
SCORE (S) / EXPRESSION (E) 
G9aMT 
S 
3 
3 
2 
2 
0 
3 
0 
2 
3 
0 
3 
1 
1 
0 
1 
0 
0 
0 
1 
1 
1 
0 
0 
1 
0 
0 
0 
E 
++ 
++ 
++ 
+ 
-
++ 
-
+ 
++ 
-
++ 
+ 
+ 
-
+ 
-
-
-
+ 
+ 
+ 
-
-
+ 
-
-
-
1.83+0.37 
0.40+0.13 
<0.001 
DNMTl 
S 
3 
2 
3 
0 
0 
3 
1 
2 
3 
1 
3 
1 
0 
0 
1 
0 
0 
0 
1 
1 
1 
0 
0 
0 
0 
0 
0 
E 
++ 
++ 
++ 
-
-
++ 
+ 
+ 
++ 
+ 
++ 
+ 
-
-
+ 
+ 
-
-
+ 
+ 
+ 
-
-
-
-
-
-
1.83+0.34 
0.27+0.12 
Bcl-2 
S 
2 
2 
1 
1 
0 
2 
1 
3 
3 
1 
2 
1 
1 
1 
1 
1 
1 
1 
1 
0 
1 
0 
1 + 
2+ 
1+ 
1+ 
0-
E 
++ 
++ 
++ 
+ 
-
++ 
+ 
++ 
+ 
+ 
++ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
-
+ 
+ 
+ 
+ 
-
1.58±0.26 
0.87+0.13 
<0.001 0.015 
p53 
S 
1 
1 
2 
0 
0 
1 
0 
2 
1 
0 
1 
0 
3 
3 
3 
2 
2 
3 
3 
3 
3 
0 
3 
2 
3 
3 
3 
E 
+ 
+ 
+ 
-
-
+ 
-
+ 
+ 
-
+ 
-
++ 
++ 
++ 
++ 
++ 
++ 
++ 
++ 
++ 
-
++ 
++ 
++ 
++ 
++ 
0.75+0.22 
2.53+0.22 
<0.001 
Bax 
S 
1 
1 
1 
0 
0 
1 
0 
2 
1 
0 
1 
0 
3 
3 
3 
3 
3 
2 
3 
3 
3 
0 
3 
3 
3 
3 
3 
E 
+ 
+ 
+ 
-
-
+ 
-
+ 
+ 
-
+ 
-
++ 
++ 
++ 
+ 
++ 
++ 
+ 
++ 
+ 
-
++ 
+ 
++ 
++ 
++ 
0.67±0.19 
2.73+0.21 
<0.001 1 
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Fig 13: Immunohistochemical (IHC) analysis of G9a methyl transferase (G9aMT) 
in Normal pregnancy (NEP) and URSA decidual/endometrial tissue system (DET) 
(A) H&E staining demonstrating Arias-Stella reaction (lOX) in NEP, 
showing glandular epithelium (GE), sheets of decidual cells (DC), and some 
blood vessels (BV) were also observed in the slides. 
(B) H&E staining of URSA tissue sample. 
(C) Positive Immuno-reactivity observed in the cytoplasm of glandular 
epithelium (GE) of NEP tissue sections. 
(D) No immuno-reactivity of G9a MT was observed in URSA. 
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Positive immuno-reactivity was observed in Glandular epithelial in NEP-DET for 
DNMTl (fig. 14). No immuno-reactivity was observed in other decidual sheet 
cells of NEP or in URSA tissue sections. The score was decreased fi"om 1.8 to 0.3 
in the DET of URSA (Table X, figure 16) with a p-value <0.001. 
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Figure 14: IHC analysis of DNA methyl transferase (DNMTl) in NEP and URSA-EP 
decidual/endometrial tissue system (DET). 
(A) Histopathological analysis performed through H&E staining shows glandular 
epithelium (GE), decidual cells (DC) and some blood vessels (BV) in the NEP 
decidual/endometrial tissue sections. 
(B) Positive Immuno-reactivity (40X) observed in the cytoplasm of glandular 
epithelium (GE) of NEP tissue sections. 
(C) Whereas, no DNMTl (40X) immuno-reactivity in the nucleus of NEP or whole of 
tissue section of URSA cases was observed. 
DET system. 
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IHC analysis for apoptosis related molecules (p53, Bcl-2 and Bax) was carried out 
in NEP and URSA-DET sections. Bax showed positive immuno-reactivity in 
cytoplasm of decidua of URSA-DET sections and no reactivity observed in 
normal tissue sections. Bcl-2 showed reverse immuno-reactivity as compared to 
Bax i.e., it was immuno-positive in cytoplasm of NEP sections. No immuno-
reactivity was observed in nucleus of Bax in NEP or URSA DET sections. 
Positive cytoplasmic and nuclear immunoreactivity of p53 was observed in the 
decidua of URSA-DET. No immuno-reactivity of Bax and p53 was observed in 
nucleus/cytoplasm in NEP DET sections. (Table X, fig 15& 16) 
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Figure 15: Immunohistochemical analysis of various apoptosis related protein in NEP 
and URSA decidual/endometrial tissue system (20X). 
(A) Bcl-2 in NEP-DET showing low but positive immunostaining around the 
glandular epithelium. 
(B) Bcl-2 in URSA-DET showing negative immunostaining. 
(C) Bax in URSA-DET showing positive decidual immunostaining. 
(D) Bax in NEP-DET showed negatively stained tissues. 
(E) p53 positive immunostaining was observed in URSA-DET of the decidual 
cells and also in the decidual nucleus. 
(F) Negative immunostaining for p53 in NEP-DET was observed. 
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Figure 16: Error Box plot representing the IHC score of NEP and URSA DET 
showing lower expression of G9aMT, Bcl-2 and DNMTl and higher expression of 
p53 and Bax in the URSA-DET. 
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6.3.2.2 Validation of IHC results through Western Blot (WB) analysis 
Western Blot (WB) analysis of certain proteins like G9aMT, DNMTl, Bcl-2 and 
Bax was performed on DET of both URSA as well as of NEP cases, after SDS-
PAGE analysis. 
6.3.2.2(a). WB analysis of Methylation related proteins in NEP and URSA-
DET cases. 
The results of Western blot (WB) analysis of the tissue protein shows decreased 
expression of G9aMT and DNMTl in the URSA cases compared to the control 
(NEP). Hence, validating the IHC results of our study. (Figure 17&18, Table XI) 
6.3.2.2(b). WB analysis of apoptosis-related proteins in NEP and URSA- DET 
cases. 
The immuno-blots obtained through WB analysis of the apoptosis related proteins 
(p53, Bcl-2 and Bax) had revealed Bcl-2 to be down-regulated, whereas up-
regulation of p53 and Bax was observed in URSA-DET. While, vice versa was 
observed in NEP i.e., Bcl-2 is up-regulated and Bax and p53 dovra-regulated, 
which is significant jfrom the results of fold change values given in Table XI. 
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Figure 17: Immuno-blot images of WB analysis of Bax, G9aMT, DNMTl, p53 and 
Bcl-2 protein in NEP (N) and URSA (R) DET system. 
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FOLD CHANGE OF WB RESULT 
4 5 6 7 
DET-PROTEIN 
1. Bcl-2 (N) 
2. Bcl-2 (R) 
3. Bax (N) 
4. Bax (R) 
5. p53 (N) 
6. p53 (R) 
7.69aMT (N) 
] 8. G9aMT (R) 
9. DNMTl (N) 
10. DNMTl (R) 
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Figure 18: Error Bar graph showing Fold change values of URSA (R)-EP-DET and 
NEP (N)-DET proteins analyzed through WB. The results clearly validated the IHC 
results of our study. 
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TABLE XI 
Result of western blot analysis showing the respective expression levels of selected 
proteins of NEP and URSA-DET. 
Samples 
Nl 
N2 
N3 
N4 
N5 
N6 
N7 
N8 
N9 
NIO 
Nil 
N12 
Rl 
R2 
R3 
R4 
R5 
R6 
R7 
R8 
R9 
RIO 
Rll 
R12 
R13 
R14 
R15 
N [M+S] 
R [M+S] 
P-value 
Bcl-2 
1 
1.29 
1.99 
— 
~ 
1.98 
— 
1.62 
1.18 
~ 
0.32 
~ 
0.4 
0.48 
0.63 
0.03 
0.32 
~ 
0.3 
0.35 
0.31 
0.33 
0.45 
0.51 
0.49 
0.44 
1 
1.34+0.22 
0.39+0.04 
<0.001 
Fold change/ Expression 
Bax 
1 
2.14 
0.97 
— 
~ 
1.19 
— 
1.1 
1.11 
~ 
1.06 
~ 
1.22 
1.62 
1.71 
2.36 
2.46 
~ 
2.39 
2.88 
1.9 
1.32 
1.99 
1.88 
2.12 
1.87 
1 
1.22+0.16 
1.98+0.12 
0.002 
p53 
1 
0.86 
1.99 
~ 
~ 
0.99 
~ 
1.74 
1.12 
~ 
0.77 
~ 
2.54 
1.39 
1.56 
1.9 
1.65 
~ 
1.69 
2.12 
1.89 
1.99 
1.5 
1.93 
2.09 
1.67 
1 
1.21+0.18 
1.84+0.09 
0.002 
G9aMT 
1.2 
1 
1.09 
~ 
~ 
1.76 
~ 
0.21 
0.41 
— 
0.92 
~ 
0.37 
0.23 
0.11 
0.08 
0.08 
~ 
0.43 
0.25 
0.3 
0.43 
0.32 
0.24 
0.23 
0.32 
1.2 
0.94+0.19 
0.26+0.03 
<0.001 
DNMTl 
1.06 
1 
0.21 
— 
~ 
0.81 
— 
0.39 
1.12 
~ 
1.1 
~ 
0.39 
0.34 
0.37 
0.39 
0.34 
~ 
0.32 
0.34 
0.3 
0.35 
0.32 
0.57 
0.47 
^2 
1.06 
0.81+0.14 
0.36+0.02 
<0.001 
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6.4 Surface characterization of endometrial/decidual tissue system (DETS) 
through SEM imaging of URSA and N£P. 
SEM was performed to identify the morphological characteristics by taking into 
account the following criteria to study the decidual/endometrial tissue system 
(DETS) of URSA and NEP: (Susan et al., 2004) 
1. Tissue heterogeneity - the variability of tissue surfaces within the sample. 
2. Cell heterogeneity - the variability of the appearance of the cell types 
within each field 
3. Gland opening - the types of gland opening, whether wide, raised, narrow. 
4. Gland abundance - the relative number of glands observed within each 
field. 
5. Cell separation - at times cells are observed to be separate rather than 
tightly clustered together. 
6. Undefined disintegrated cell types. 
7. Presence of lymphocytes: In the form of NK cells, T-Cell, B-Cells, etc. 
Table XII shows abimdant glands with wide openings, tissue heterogeneity, a 
well defined cell separation, healthy RBCs along with excessive NK cells in the 
SEM images of NEP DET. While the URSA-DET SEM images clearly showed 
narrow gland openings, absence of well defined cell morphology, tissue 
homogeneity, and few NK cells compared to that of NEP. (Table XII, Fig 19) 
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TABLE-XII 
Observation of SEM images of NEP and URSA- DET cases. 
Samples 
Nl 
N2 
N3 
N4 
N5 
N6 
N7 
N8 
N9 
NIO 
Nil 
N12 
R13 
R14 
R15 
R16 
R17 
R18 
R19 
R20 
R21 
R22 
R23 
R24 
R25 
R26 
R27 
Characterization Criteria for DET 
Tissue 
heterogeneity 
H 
TH 
TH 
TH 
TH 
TH 
TH 
TH 
TH 
TH 
TH 
TH 
H 
TH 
H 
TH 
H 
H 
TH 
H 
H 
H 
TH 
H 
H 
TH 
H 
Gland 
opening 
N,S 
N,S 
N,S 
N,S 
N,S 
N,W&S 
N,S 
N,S 
S 
u,w 
s,u 
s,u 
u,w 
u,w 
u,w 
u,w 
u,w 
U,N 
u,w 
N 
u,w 
N 
U,N 
W 
u 
N 
N 
Gland 
abundance 
<10 
>10 
>10 
>10 
>10 
>10 
>10 
>10 
>10 
-10 
>10 
>10 
>10 
>10 
>10 
-10 
>25 
>10 
>10 
<10 
<10 
<10 
>10 
<10 
<10 
<10 
<10 
Cell 
separation 
X 
/ 
/ 
/ 
/ 
/ 
X 
/ 
/ 
X 
/ 
/ 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
/ 
X 
X 
Undefined 
disintegrated 
cell types 
/ 
X 
X 
X 
X 
X 
/ 
X 
X 
X 
X 
X 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
/ 
NK-cells 
(approx.) 
20 
17 
24 
26 
29 
19 
13 
20 
17 
12 
34 
21 
12 
13 
8 
9 
2 
4 
5 
8 
6 
10 
6 
3 
4 
7 
10 
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FIGURE 19 
PHOTOMICROGRAPHS OF SEM IMAGES OF 
DECIDUAL/ENDOMETRIAL TISSUE (DET) OF NORMAL EARLY 
PREGNANCY (NEP) AND OF UNEXPLAINED RECURRENT 
SPONTANEOUS ABORTION (URSA) SHOWING NK CELLS THROUGH 
ARROWS WHILE BRACKETS SHOWS THE GLANDS WITH 
THEIR RESPECTIVE MAGNIFICATIONS. 
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6.5. Receiver operating characteristic (ROC) curve analysis 
6.5.1 ROC curve analysis of mRNA expressions obtained through RT-PCR 
Receiver operative characteristics (ROC) curve analysis was used to compare 
results of RT-PCR analysis to identify the gene most affected during URSA from 
the panel of genes. 
The ROC analysis as shown in Graph ofBcl-2 gene showed 91.67% true positive 
cases [Figure 20, Table XIII (a)] and 93.33% true negative cases, with the area 
under the curve (AUC) of 0.99 again provided the substantiation of proper 
discrimination between the normal (NEP) and the abnormal (URSA) cases as the 
AUC lies within the range of 0,5-1.0. The 95% confidence interval was observed 
from (0.85 to 1.00) with a cut-off point of 0.42 for normal below which the 
samples were found to be involved in pathogenesis of URSA with a significant p-
value(< 0.001). 
Box showed 91.67% true positive cases and 93.3% true negative cases at a cut 
point of 0,4 at mRNA level, indicating values higher than the cut off values of bax 
to be related to URSA with a 95% confidence interval between 0,80 - 0.99 with 
statistically significant p-value of < 0.001. 
The gene p53 AUC was observed to be 0.84 with a cut off value of 0.83, higher 
values involved in etio-pathogenesis of URSA and lower in maintenance of 
normal pregnancies with a 95% confidence interval between 0.67 to 0.95 (p-value 
of <0.01). [Figure 20, Table XIII (a)] 
The G9aMT gene, a methylation related gene and the gene involved during early 
embryogenesis showed a sensitivity of 66.67% and the specificity 66.67% with cut 
off point of 0.44, lower values indicate URSA and higher normal pregnancy. It is 
not so good predictor of URSA at the gene level with no significant difference 
between the control and the URSA cases. The ROC analysis showed the AUC to 
be 0.75 which is lesser than the apoptotic related genes with a 95% confidence 
interval of (0.56 - 0.93). (Figure 20, Table XIII (a)) 
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Figure 20: ROC curves of genes analyzed through RT-PCR. Showing their 
respective Area under the curve (A) representing Bcl-2 having the highest A 
followed by Bax, p53, G9aMT and DNMTl 
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The recruitment of G9a to DNMTl perhaps coordinates histone and DNA 
methylation long after DNA replication. Furthermore, due to the low catalytic 
turnover of DNMTl (Pradhan et al. 1999) stimulation by G9a may aid DNA 
methylation. This is well understood by our results of DNMTJ showing a lower 
sensitivity of 58.33% and specificity of 60% in URSA compared to higher values 
for G9aMT with a cut-off point of 0.55, lower values indicative of URSA. The 
ROC analysis showed the lowest AUG of 0.69 compared to all the other genes 
studied with a 95% Confidence interval was observed to be (0.49-0.89). 
The AUC difference as shown in Figure 20 and the values as in table XIII (b) 
showed pair-wise evaluation of the genes in URSA cases indicating Bcl-2~Bax to 
have a non-significant p-value stating lowest area difference (A.D) and no 
difference in sensitivity and specificity observed in Box or Bcl-2 both consisting of 
highest values (table XIII (a)) suggesting the genes to be effected the mosX during 
URSA as compared to the other genes. Likewise could be said for the p53 gene 
showing the second highest sensitivity and specificity (table XIII (a)). The 
Bax~p53 and Bcl-2~p53 pair showed almost the same A.D indicating p53 to be 
equally placed below Bcl-2 and Bax in the ROC curve. The results direct that the 
mRNA analysis of Bcl-2, Bax and p53 could advantageously and successfiilly 
discriminate the URSA and NEP cases during the early pregnancy in the human 
females. 
Through ROC it could be said that Bcl-2 and Bax are the genes which are equally 
affected during URSA also the/?55 gene expression is affected the most in URSA. 
G9aMT and DNAdTl were not much affected during EP, also their low sensitivity 
and specificity was found to be statistically non-significant between the two 
groups of our study at mRNA level. 
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Table Xin 
(A). ROC analysis of RT-PCR analyzed genes 
GENE 
Bax 
Bcl-2 
DNMTl 
G9aMT 
P53 
Sensitivity 
91.67% 
91.67% 
58.33% 
66.67% 
83% 
Specificity 
93.3% 
93.3% 
60% 
66.67% 
80% 
AUG 
0.958 
0.986 
0.692 
0.750 
0.844 
SE 
0.04 
0.02 
0.11 
0.09 
0.08 
95%CI 
0.80-
0.99 
0.85-
1.00 
0.49-
0.85 
0.54-
0.89 
0.65-
0.95 
p-value 
<0.0001 
<0.0001 
0.08 
0.028 
0.002 
(B). Pair-wise evaluation of genes in ROC 
Pair 
DNMTl ~ 
G9aMT 
Bcl-2 ~ DNMTl 
Bax ~ Bcl_2 
Bax ~ DNMTl 
Bax ~ G9aMT 
Bax ~ p53 
Bcl-2 ~ G9aMT 
Bcl_2 ~ p53 
DNMTl ~ p53 
G9aMT~p53 
A.D* 
0.059 
0.315 
0.006 
0.321 
0.262 
0.137 
0.256 
0.131 
0.185 
0.125 
S.E* 
0.115 
0.109 
0.027 
0.102 
0.098 
0.070 
0.102 
0.074 
0.113 
0.091 
95%C.I.* 
-0.166 to 0.285 
0.101 to 0.530 
-0.047 to 0.059 
0.122 to 0.521 
0.069 to 0.455 
-0.001 to 0.275 
0.056 to 0.456 
-0.015 to 0.277 
-0.038 to 0.407 
-0.054 to 0.304 
p-value 
0.605 
0.004 
0.825 
0.002 
0.008 
0.052 
0.012 
0.079 
0.103 
0.171 
*AD= Area difference; S.E= Standard error; C.l= Confidence interval. 
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6.5.2. ROC ANALYSIS OF THE PANEL PROTEINS OF THE URSA 
CASES DURING THE FIRST TRIMESTER: 
6.5.2. (a). ROC for comparing IHC results 
Receiver operative characteristics (ROC) curve analysis was used to compare 
results of IHC analysis to identify the protein most affected during RSA from the 
panel of proteins. 
The ROC analysis shown in Figure 21 of Bax and p53 with cut-off value of 1.5 
indicates higher values to be indicative of URSA showing 91.67% true positive 
cases [Table XIV (a)] and 93.33% true negative cases, with the area under the 
curve (AUC) of 0.95 again provided the substantiation of proper discrimination 
between the normal (NEP) and the abnormal (URSA). The 95% confidence 
interval was observed from 0.85 to 1.00 and the p-value was found to be < 0.001, 
which is again indicative of a statistically significant result. 
Bax stood on second position in discriminating the URSA cases from the NEP 
through IHC with a sensitivity of 91.67% and specificity of 93.33% then the 
protein descends from p53, DNMTl, G9aMT to Bcl-2. 
Bcl-2, G9aMT and DNMTl have a cut-off value of 1.5, 0.5 and 0.5 respectively, 
higher values indicative of NEP and lower indicative of URSA. 
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Figure 21: ROC curves showing the AUG (A) of the proteins analyzed through 
IHC. 
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Table XIV 
(a). ROC curve analysis result of IHC. 
GENE 
G9aMT 
DNMTl 
BcI-2 
Bax 
P53 
URSA-DET 
Sensitivity 
75% 
83.33% 
50% 
91.67% 
83.33% 
Specificity 
60% 
73.33% 
93.33% 
93.33% 
93.33% 
AUG 
0.808 
0.861 
0.733 
0.944 
0.931 
SE 
0.09 
0.08 
0.10 
0.05 
0.05 
95%CI 
0.612-
0.933 
0.674 -
0.963 
0.529 -
0.884 
0.783 -
0.996 
0.763 -
0.992 
value 
0.007 
0.002 
0.040 
< 
0.0001 
0.0001 
(b). Pair-wise ROC curve analysis result of all the protein molecules analyzed through 
IHC. 
Pair 
Bax~Bcl-2 
Bax-DNMTl 
Bax~G9aMT 
Bax ~ p53 
Bci-2 ~ DNMTl 
Bcl-2 ~ G9aMT 
Bcl-2~p53 
DNMTl ~ G9aMT 
DNMTl ~ p53 
G9aMT~p53 
A.D* 
0.223 
0.083 
0.137 
0.015 
0.140 
0.086 
0.208 
0.054 
0.069 
0.122 
S.E* 
0.0854 
0.0720 
0.0800 
0.0500 
0.100 
0.106 
0.101 
0.0655 
0.0689 
0.0860 
95%C.I.* 
0.0558 to 0.391 
-0.0578 to 0.224 
-0.0199 to 0.294 
-0.0832 to 0.113 
-0.0562 to 0.336 
-0.121 to 0.294 
0.0102 to 0.406 
-0.0748 to 0.182 
-0.0667 to 0.204 
-0.0465 to 0.291 
p-value 
0.009 
0.247 
0.087 
0.766 
0.162 
0.414 
0.039 
0.413 
0.321 
0.156 
*AD= Area difference; S.E= Standard error; C.I= Confidence interval. 
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6.5.2. (b). ROC analysis of the western blot results of panel of proteins of the 
URSA cases during the first trimester. 
Receiver operative characteristics (ROC) curve analysis was used to compare 
results of WB analysis to identify the protein most affected during URSA from the 
panel of genes. 
The ROC analysis as shown in Figure 22 and Table XV (a), Bax cut-off value of 
0.39 upper values showed 84.6% true positive cases [Table XV (a)] and lower 
values showed 85.7% true negative cases, with the highest area under the curve 
(AUC) of 0.90 again provided the substantiation of proper discrimination between 
the normal (NEP) and the abnormal (URSA). The highest AUC was observed in 
the cases of Bax with least S.E holds the first position in the panel of proteins able 
to discriminate between the URSA and NEP cases through WB followed by Bcl-2 
(0.38), p53(0.39), G9aMT (0.38) and DNMTl (0.40) with their respective cut-off 
value. Bcl-2, G9aMT and DNMTl lower values indicate presence of URSA while 
reverse is valid for p53. 
The pair-wise analysis (Table XV (b)) of the genes again gave the statistically 
insignificant p-values which showed not much difference between the molecules. 
Hence WB validated our IHC results very well. 
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Figure 22: WB-ROC analysis of the protein molecules. 
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Table XV 
(A): ROC curve analysis showing results of the protein analyzed through WB 
GENE 
G9aMT 
DNMTl 
Bcl-2 
Bax 
P53 
Sensitivity 
71.43% 
71.43% 
85.71% 
84.6% 
84.6% 
Specificity 
78.92% 
69.23% 
84.62% 
85.7% 
85.7% 
URSA-B 
AUC 
0.87 
0.84 
0.89 
0.90 
0.84 
•ET 
SE 
0.11 
0.12 
0.10 
0.09 
0.11 
95%CI 
0.64 to 0.98 
0.60 to 0.96 
0.67 to 0.98 
0.67 to 0.98 
0.60 to 0.96 
P-
value 
0.008 
0.016 
0.004 
0.003 
0.015 
(B); Pair-wise analysis of WB-ROC results 
Pair 
Bax~BcI-2 
Bax-DNMTl 
Bax~G9aMT 
Bax ~ p53 
BcI-2 ~ DNMTl 
BcI-2 ~ G9aMT 
Bcl-2 ~p53 
DNMTl ~ 
G9aMT 
DNMTl ~ p53 
G9aMT~p53 
A.D* 
0.0110 
0.0659 
0.0330 
0.0659 
0.0549 
0.0220 
0.0549 
0.0330 
0.000 
0.0330 
S.E* 
0.103 
0.116 
0.109 
0.103 
0.0936 
0.120 
0.104 
0.122 
0.108 
0.120 
95%C.I.* 
-0.190 to 0.212 
-0.162 to 0.294 
-0.180 to 0.246 
-0.136 to 0.268 
-0.129 to 0.238 
-0.212 to 0.256 
-0.149 to 0.259 
-0.206 to 0.272 
-0.211 to 0.211 
-0.202 to 0.268 
Z statistic 
0.107 
0.567 
0.303 
0.640 
0.587 
0.184 
0.528 
0.270 
0.000 
0.274 
p-value 
0.915 
0.571 
0.762 
0.522 
0.557 
0.854 
0.597 
0.787 
1.000 
0.784 
*AD— Area difference; S.E= Standard error; C.I= Confidence interval. 
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6.5.3 ROC ANALYSIS OF THE SEM CHARACTERISTIC CRITERIA OF 
THE DET OF URSA AND NEP CASES. 
Receiver operative characteristics (ROC) curve analysis v^as used to discriminate 
between the set of chosen characteristic- criteria of SEM images for analyzing the 
criteria which could be used without any error for discriminatmg the URSA-DET 
from NEP-DET SEM analysis. 
The results as observed in Figure 23 and Table XVI are considered in plotting 
ROC curve which had given result as described in table XVI led us to say that in 
SEM imaging tissue heterogeneity, cell separation, undefined disintegrated cell 
types and NK cells were found to be statistically significant criteria. To consider 
the best criterion for judging the DET under SEM the highest sensitivity and 
specificity was considered which was found to be highest for NK cells followed 
by the criterion of differentiating Undefined disintegrated cell types and also the 
criterion of cell separation in SEM imaging could differentiate the URSA-DET 
fix)m that of NEP- DET SEM. 
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SEM-ROCcurve analysis 
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Figure 23: ROC analysis of SEM- characteristic criteria of 
DET 
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TABLE XVI 
Result of SEM-ROC analysis of NEP and URSA-EP-DET. 
SEM 
Characteristic 
criteria of 
DET 
Tissue 
heterogeneity 
Gland 
opening 
Gland 
abundance 
Cell 
separation 
Undefined 
disintegrated 
cell t yp^ 
NK-cells 
(approx.) 
URSA-DET 
Sensitivity 
91.67 
75% 
83.33 
75% 
83.33 
91.67% 
Specificity 
66.67 
73% 
53.33 
93.3% 
100.00 
93.33% 
AUC 
0.792 
0.697 
0.672 
0.842 
0.917 
0.989 
SE 
0.0912 
0.101 
0.107 
0.0812 
0.0558 
0.0222 
95%CI 
0.593 to 0.923 
0.491 to 0.858 
0.466 to 0.839 
0.651 to 0.953 
0.745 to 0.988 
0.852 to 1.000 
P-
value 
0.0014 
0.0518 
0.1073 
0.0001 
0.0001 
0.0001 
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Recurrent Spontaneous abortion (RSA) is a clinical entity which includes the cases 
of two or more consecutive abortions during early pregnancy (Meka and Reddy, 
2006). Approximately 50%-75% are not associated with any detectable pathology 
hence they are labeled as unexplained recurrent spontaneous abortions (URSA). 
Like RSA, URSA is also classified into primary URSA (i.e., with no live birth) 
and secondary URSA (i.e., with live birth), having two or more consecutive such 
types of idiopathic abortions. (Meka and Reddy, 2006). In view of undeniable 
socio-economic importance of URSA which influences personally, communally 
and economically (Singh (1996), Leke et al., (1996) and Yeboah et al., (1992)), 
and non availability of any known confirmatory test or scientific treatment made 
the basis to conduct this study so as to help in designing a diagnostic protocol 
initially and to propose further study to find out the solution of this problem 
subsequently. Absence of congenital, fetal, inflammatory, traumatic, neoplastic, 
degenerative or biochemical factors in URSA led us to explore the least explored 
field of epigenetic/genetic to achieve our aforesaid goal. 
Exhaustive search of literatures revealed scanty nature of work done in this field 
of URSA, The expression analysis of certain pregnancy related genes at transcript 
and/or protein level was reported to be altered by various workers during RSA as 
compared to NEP. 
However, the DNA methylation is one of the main epigenetic modifications of 
DNA in mammals, and is involved in tissue-specific gene expression, X-
chromosome inactivation, genomic imprinting, immobilization of mammalian 
transposons, and suppression of transcriptional noise (Bird & Wolffe 1999; D. 
Takai & Jones, 2001; Reik et al. 2001). 
DNMTl and G9aMT are the molecules found to be actively involved in the 
methylation of DNA and also it is reported earlier that the absence or down-
regulation of the genes DNMTl and G9aMT was found responsible in embryonic 
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lethality and also related to increased apoptosis during early pregnancy (Li et al 
1992; Tachibana et al 2002). Further work of Esteve et al (2006) proved that the 
normal methylation of replicating chromatin could be disturbed by knocking down 
of DNMTl with the help of small interfering RNA (siRNA) despite of the 
presence of G9aMT, which proves that G9aMT alone could not maintain the 
normal DNA methylation/silencing of related genes. As it has also been reported 
by Tachibana et al 2002 that aberration of Gene G9a leads to embryonic lethality 
during early embryogenesis hence presence of both DNMTl and G9aMT are 
essential for normal embryogenesis and methylation. And this is the reason to 
include both the methylation related molecules in our study. 
Jackson-Grusby et al (2001) and Pham et al (2003) reported the over expression 
of p53 due to loss of genomic methylation which made the basis of expression 
analysis of p53 at the transcript and protein level along with the analysis of its 
methylation status in URSA in our study. 
Apoptotic event were studied in the cases of RSA using TUNEL assay and/or 
expression analysis of pro-apoptotic gene bax and/or anti-apoptotic expression of 
Bcl-2 by Sugino et al (2000), Smith et al (1997), Peng Wei et al (2005), Falco et al 
(2001), Qiao et al (1998), Gabriela et al (2000) and Jackson-Grusby et al (2001) 
made the basis to study the apoptosis by TUNEL assay and expression analysis of 
apoptosis related genes Bax and Bcl-2 at transcript and protein level in our study. 
Epigenetic modulations were found to be pivotal in alteration of the expression of 
genes at the transcript level. 
Cre-mediated deletion of Dnmtl causes Loss of genomic methylation and p53-
dependent apoptosis leading to epigenetic deregulation of methylation related 
molecule Dnmtl which is found to be responsible for 
demethylation/hypomethylation of p53 leading to apoptosis (Jackson-Grusby et 
al., 2001), the role of apoptosis in causation of abortion (Bertoja et al., 2005) and 
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the role of methylation in causation of abortion [Bagislar et al., 2006] have been 
studied. The role of hypomethylation of p53 in over expression of apoptotic genes 
and a simultaneous under expression of methylating enzyme DNMTl is an already 
known phenomenon but in the cases of renal fetal morbidity in rats only, resulting 
into reduced utero-placental insufficiency (Pham et al., 2003).The findings of 
expression of these genes are in congruent with the findings of our study which 
states that the hypomethylation of gene p53 is related to the over expression of 
gene p53. Hypomethylation of gene p53 is responsible for different expression of 
apoptosis related genes (Bax and Bcl-2) and is related to down regulation of 
methylation related gene DNMTl and G9aMT in the cases of URSA which is 
opposite to the findings observed in NEP of our study. 
Peng Wei et al., (2005) studied the maternal-fetal mterface of Rhesus monkey and 
reported the level of p53 to be lower and Bcl-2 level to be higher during early 
pregnancy yet another finding of Sugino et al., (2000) showed a relation of higher 
expression of Bcl-2 and lower expression of Bax in maintenance of normal 
pregnancy. Our study was in total accordance to their findings in the cases of 
normal pregnancy , but the finding of increased p53 in the late pregnancy related 
to causation of apoptosis is absent in our study as we have not taken the late 
pregnancy cases as is already set through our inclusion and exclusion criteria. 
Significantly we observed that instead of late pregnancy apoptosis occurs during 
early pregnancy in cases suffering fi-om URSA due to elevated expressions of p53. 
An important study conducted by Lea et al., 1997 showing Bcl-2 immunostaining 
demonstrated a difference in expression of Bcl-2 in three groups of surgical 
termination, miscarriage and sporadic abortion, in which first trimester failing 
pregnancies did not reveal any differences between incipiently miscarrying 
patients with and without a history of recurrent miscarriage. All failing 
pregnancies, however, did exhibit less intense bcl-2 immunostaining of the 
syncytiotrophoblast compared with the surgical termination group which made us 
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confident enough to inform the role of Bcl-2 in maintenance of normal pregnancy 
and its altered expressions in the cases of URSA has provided strength to our 
finding. 
Studies on some reproductive defects like that of endometriosis had also been 
conducted on some molecules like the work of Gabriela et al., (2000) found an 
increased expression of Bcl-2 protein in proliferative eutopic endometrium from 
patients with endometriosis. Whereas, Bax expression was absent in proliferative 
endometrium, also observed was an increase in its expression in secretory 
endometrium from both patients and controls made them to conclude that women 
with endometriosis show decreased number of apoptotic cells in eutopic 
endometrium. The abnormal survival of endometrial cells may result in their 
continuing growth into ectopic locations. 
Another work on reproductive related abnormality performed by Qiao et al., 
(1998) through hnmunohistochemistry of biopsy samples in Complete 
Hydatidiform mole (CHM) showed higher apoptosis index in cytotrophoblasts in 
Complete Hydatidiform Mole (CHM). Strong p53 expression and an increase in 
the Bax/Bcl-2 ratio were also observed in CHM suggesting their contribution in 
high level of apoptosis. Hence, this study is in concomitance to our findings of an 
increased Bax/Bcl-2 ratio as well as a positive TUNEL Assay in URSA. 
A study conducted by Susanne et al., (1995) suggested that p53 is over expressed 
not only in choriocarcinoma cells but in certain trophoblast cell populations of the 
human placenta as well i.e., of term pregnancy. Smith et al., (1997) showed 
significantly increased Placental apoptosis as the pregnancy progresses, suggesting 
that it may play a role in the normal development and aging of the placenta. 
Whereas our study suggests that if this increase in apoptosis is observed at an 
earlier stage of pregnancy during the first trimester it results into URSA. 
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Earlier work has already proved the role of apoptosis in causing menstruation and 
normal child birth in the late pregnancy (Sugino et a l , 2000). But the role of 
apoptosis was not explored in the cases of early pregnancy especially in the cases 
of abortions. This missing link was recognized by us and the study have been 
planned to explore the role of apoptosis in the cases of early pregnancy and in the 
cases of unexplained abortion during early pregnancy. 
To the best of our knowledge none of the study could be traced which can 
successfully correlate the role of p53 methylation and apoptosis either in the 
maintenance of normal pregnancy or in the causation of URSA particularly in 
India. 
Whereas, Li et al., (1992) and Tachibana et al., (2002) showed that euchromatic 
H3-K9 methylation regulated by DNMTl and G9a is essential for early 
embryogenesis and is involved in the transcriptional repression of developmental 
genes and study conducted by Esteve et al., (2006) showed that two global 
epigenetic enzymes, DNMTl and G9a, coordinate synchronized DNA and histone 
H3K9 methylation during DNA replication. 
But the role of certain methylation related genes like G9aMT and DNMTl is 
meagerly understood for its correlation with the etio-pathogenesis of URSA. 
Through our study we found expression of both the methylation related genes 
DNMTl and G9a MT to be expressed normally during NEP helping in 
maintaining pregnancy whereas a down regulation in their expression was 
observed in the DETS resulting into URSA during early pregnancy. 
On another hand, work of Jackson-Grusby et al., (2001) showed that cre-mediated 
deletion of DNMTl induces p53-dependent apoptosis, supports our study and 
helped us in correlating the results showing induction of apoptosis during URSA 
where expression of DNMTl is low as compared to that found in NEP. 
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Also our study concluded that not only in URSA, the hypomethylation of gene p53 
has been established. But in view of existing literature it is found that this 
relationship is consistent finding in other abnormal pregnancy associated with 
different type of pathogenesis. 
The study under report has been designed with utmost care and strict adherence to 
the inclusion and exclusion criteria for achieving merely complete homogeneity in 
and among the study group of the cases of normal pregnancy and URSA and also 
to avoid the effect of other miscellaneous factors like congenital anomahes, 
hormonal alteration, nutritional factors, and any other factors even like sporadic 
fetal chromosomal abnormality as a cause of RSA. (Kara et al., 2007) 
Explained accounting of the collected samples of Decidual/Endometrial tissue 
system (DETS) from the subjects respecting the ethical norms in the form of 
obtaining informed consent from individual patients as well as the head of the 
Department and Institution, makes this study ethical and transparent. 
The results of IHC and western blot has successfully established the expected 
reciprocal relationship of the expression level of genes Bcl-2, G9aMT and 
DNMTl versus p53 and Bax which is in accordance with the results of Jackson-
Grusby et al., (2001), Wyllie, (1994), Oltavi et al., (1993), Parr et al., (1987), 
Piacentini and Autori, (1994) Akcali et al., (1996), and no literature could be 
traced in contravention till date. 
The reciprocal relationship through Immuno-histochemistry could be explained by 
the elevated expression of G9aMT, DNMTl and Bcl-2 while low expression level 
of p53 and Bax were observed in NEP whereas the reverse occurs during URSA. 
Also TUNEL positive nuclei were observed in the RSA cases of first trimester 
which is a reciprocal finding as that observed by Falco et al., (2001) which 
represented TUNEL positive nuclei of placenta in the late normal pregnancy and 
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TUNEL negative placental nuclei in the first trimester normal pregnancy 
indicating early apoptosis in RSA. 
Our Western blotting results show elevated expression level of Bcl-2, DNMTl and 
G9aMT with higher fold change value in NEP whereas these molecules were 
found to be showing low expression in URSA cases with a lower fold change 
value as given in table XL Whereas, elevated expression (i.e., higher fold change 
value) of p53 and Bax was observed in URSA and the same were down regulated 
in NEP. This result of higher expression of DNMTl and G9aMT, with the lower 
expression of p53 was found in accordance to the study of Jackson-Grusby et al., 
(2001) without contravention in any traceable parallel studies. The finding of the 
expression of Bcl-2 and Bax in the DETS was also in accordance with the study of 
Compel et al., (1994); Otsuki et al., (1994); Koh et al., (1995); McLaren et al., 
(1997). 
Inversion of the reciprocal relationships among the genes has been observed in the 
cases of URSA with respect to normal pregnancy was also found with accordance 
to the finding of Parr et al.,(1987); Piacentini and Autori, (1994); Akcali et al., 
(1996) 
The confirmation of the expression of Bcl-2, Bax, p53, G9aMT and DNMTl has 
specifically been confirmed through mRNA expression by performing Reverse 
Transcription PCR (RT-PCR) to remove all traces of doubts. The status of p53 
methylation has been assessed by the expression level of DNMTl and G9a MT 
which was found to be in accordance v^ dth the result of Jackson-Grusby et al., 
(2001) and Egger et al., (2004). 
Confirmation of the status of p53 methylation status was performed by MS-PCR. 
The hypomethylation of p53 and over expression of umnethylated p53 was 
observed in the cases of URSA. Whereas, the hypermethylation of p53 and low 
expression of unmethylated p53 was found in the normal pregnancy cases. 
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In view of aforesaid from which it is evident that the study under report has 
successfully explained the scientific reasons with their confirmation beyond doubt 
in establishing the relationship among methylation, apoptosis and pregnancy. 
A. definite drift in the form of inversion of reciprocal relationship in the case of 
URSA as compared to normal pregnancy has been detected with consistency in 
confirming the most probable etio-pathogenesis to explain the cases of 
unexplained RSA. 
Further follow up of the cases in which the results of the tissue samples were not 
congruent with the expected result of the rest of the group, it was found that these 
women were indulged in consuming unbranded traditional substances given by 
certain quacks when asked afterwards. 
Considering the severity and importance of the cases of URSA within the ambit of 
this work in which we have studied certain factors in the endometrial/decidual 
tissue system only, we have also done the surface characterization of 
endometrial/decidual tissue system (Susan et al., 2004) by SEM imaging in an 
attempt to develop an instantaneous diagnostic tool for screening the cases of 
URSA. 
Attempts have been made for surface characterization of DETS through SEM by 
Kara et al., (2007). Our results of surface characterization were identical with the 
findmg of their study showing a decrease in the number of decidual NK cells and 
an increase in the number of lymphocytes in the miscarriage group despite of the 
difference in staining and model of SEM machines. 
We performed the statistical analysis through Receiver operative characteristic 
curve (ROC) and student-T-test. To the best of our knowledge we have for the 
first time performed the ROC analysis for SEM, which led us to predict NK cell 
number to be the best differentiating criteria through SEM between URSA and 
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NEP of the DET with highest sensitivity and specificity (Table XVI) and a 
significant p-value as well. 
We can clearly see that the ROC analysis appeared to fetch different values for all 
the molecular factors in different tests. But observing the overall results we can 
clearly say that Western Blot analysis gave a consistent resuh for almost all the 
molecules under study whereas if a researcher is studying a particular molecule 
say at gene level through RT-PCR then it would predict the sensitivity of the 
mRNA for URSA through Bcl-2 at its best and also the same results could be 
obtained through WB, but if the same molecule is considered for that in IHC then 
it is possible that the results won't be that accurate in predicting URSA through 
DET of a patient but it will predict NEP. 
When pair-wise analysis of the respective ROC curve was carried out the 
insignificant p-values showed the least difference between the molecules and 
significant values depicted the difference between the two molecules. So through 
the above discussion we can predict that the methylation related genes DNMTl 
and G9aMT along with an apoptotic gene Bcl-2 and Bax could predict URSA 
cases through DET during the early pregnancy in the Indian population, 
reconfirming that the deviation of level of expression fi*om the control/normal of 
the apoptotic genes as well as methylating genes are interrelated with each other in 
causation of URSA. 
The study clearly substantiates the role of demethylation of gene p53 in causing 
URSA through the apoptotic pathways. Though results of all the tests were found 
to be statistically significant but the test of WB for Bax and Bcl-2 could be used 
successfully in diagnosing the cases of URSA while the SEM unaging of DETS 
emerged as best modality to screen the cases of URSA. 
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Summary and conclusion of the salient findings of the study: 
1. A consistently higher methylation expression of gene p53 was found higher 
in all of our study cases of early normal pregnancy and gene p53 
hypomethylation was observed in URSA. 
2. A direct relationship between the expression of methylation related gene 
G9aMT, DNMTl with the degree of methylation of gene p53 was found, 
i.e., with higher expression of DNMTl and G9aMT resulted into higher 
methylation of gene p53 and lower expression of the same led to 
hypomethylation of gene p53. 
3. Low fold change value of gene p53 (0.69+0.04) in normal early pregnancy 
(NEP) and comparatively high fold change value of (1.64+0.26) in cases of 
unexplained recurrent spontaneous abortion (URSA) has been observed in 
the decidual/endometrial tissue (DET) samples of our study. 
4. The reciprocal relationship among the anti-apoptosis related gene Bcl-2 
versus pro apoptotic gene Bax and tumor suppressor gene p53 has been 
found in our study shovving high Bcl-2 expression in NEP compared to 
DETS of URSA. 
5. The surface characterization of DETS on SEM imaging has been 
established to differentiate/screen the cases of URSA with lesser number of 
NK cells as compared to that of NEP and was observed as the best criteria 
of differentiation between NEP and URSA as analyzed through ROC. 
6. Finally, the role of hypomethylation of the apoptosis regulating gene p53 
has been established in causation of URSA through the process of 
apoptosis. 
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7. The aforesaid analysis also point towards the pivotal role played by 
methylation of the gene p53 in causation of URSA and hence the 
manipulation of methylation by certain agents/drugs could advantageously 
be used for a desired outcome. The level of methylation of a gene could 
successfully be altered as desired, by any methylating/demethylating 
agent(s) and/or drug(s), provided their use should be devoid of causing any 
side effects. 
8. With the help of the results obtained through our work, further study could 
be undertaken in a direction to design a protocol to either terminate 
unwanted pregnancies or for population control. 
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JApj>endix 
Appendix I 
Performa and Consent 
1. SAMPLE NO./REG.NO./HOSPITAL NAME/DOA: 
2. DATE & TIME OF SAMPLE COLLECTION: 
3. DOCTOR ON DUTY: 
4. NAME/AGE OF PATIENT (WEIGHT/HEIGHT IF AVAILABLE): 
5. DATErfEARS OF MARRL^GE: 
6. TIME OF MENARCHY: 
7. PREVIOUS HISTORY OF DELIVERY/ABORTION(S): 
8. MOBILITY AND HISTORY OF SEXUAL CONTACT DURING 
PREGNANCY: 
9. CLINICAL CAUSE OF ABORTION/HISTORY OF PATIENT: 
10. MEDICAL AND SURGICAL HISTORY: 
11. MEDICATIONS: 
12. FAMILY HISTORY: 
13. SOCIAL HISTORY: 
14. PHYSICAL EXAMINATION: 
15. ASSESSMENT: 
16. CONSENT OF PATIENT: 
I hereby approve to use the tissue and blood samples obtained during abortion for 
scientific research purpose without any problem/objection. I also hereby approve the 
above given information to be accurate, correct and also verified by me in person. I also 
have no objection for publication of the data of this study in scientific literature or 
elsewhere if it is required to be published in public benefit/interest. I also give my 
consent for this material to appear in any international/national publications. 1 have seen 
any pictures and read the material to be published. 
I understand that: 
• My name will not be published. I understand, however, that complete anonymity 
cannot be guaranteed. 
• The material may be published in the weekly print copy of any national/international 
journals and associated publications, which has a large/small circulation. 
• The material may also be placed on any of the international/national journal 
worldwide website. Both the printed version and the website are seen and read by 
doctors, journalists, and members of the public. 
• The material may also be used by the books. 
• The material will not be used for advertising or packaging. 
• The material will not be used out of context. 
Signature (or thumb print): 
Date: 
Print name: 
If you are not the patient, what is your relationship to them? 
Witness: Date: 
Sample collection done by: Impartial witness: 
Appendix II 
Inclusion/Exlusion criteria for selection of the subject of NEP and RSA-EP 
SNo Subjects Criteria for pregnant women 
General Inclusion- Exclusion criteria for NEP and RSA-EP 
1. Include the subject if all are "No" 
2. Exclude the subject if any is "Yes" 
Yes No 
Subjects of ages less than 20 yrs or more than 30 years. 
b. Subjects positive for HIV antibody. 
c. Subjects suffering/with of urogenital infection. 
d. Subjects suffering from menstrual/hormonal irregularities. 
Subjects associated with congenital/ genetic/ anatomical 
abnormalities/malnutrition or with other diseases like 
Tuberculosis/diabetics/hypertension/typhoid/pyrexia of unknown origin 
(PUO). 
Unwanted uterine pregnancy because of failure of oral or injectable 
contraceptives (Hormonal-contraception) 
Subjects who have attempted any other means of abortion. 
h. Subjects undergoing surgical abortions (D&C procedure) for pregnancy more 
than the duration of 12"^  week duration. 
Subjects who had developed any significant disease, such as pre-eclampsia, 
eclampsia, hydatidiform mole (HM), endometriosis or having history of drug 
intake such as prostaglandin, acetyl salicylic acid and antibiotics. 
Specific Inclusion- Exclusion criteria for NEP 
Include subject if all are "Yes" 
Exclude subject if anyone is "No" 
Subjects with unwanted embryonic pregnancy (under MTP act) may or may 
not be due to failure of use of contraception devices like condom and lUD. 
Early pregnancy not manifested as threatened/inevitable or incomplete 
abortion. 
k. 
Specific Inclusion- Exclusion criteria for RSA-EP 
1. Include subject if it is "Yes" 
2. Exclude subject if it is "No" 
m. 
Subjects undergoing dilatation & curettage (D&C) due to inevitable/ 
incomplete abortion of less than 24 hours duration for uterine pregnancies of 
up to 12 weeks without visible evidence of any embryonic abnormality (like 
hydatidiform moles, etc). 
Subjects having history of two or more such types of consecutive recurrent 
spontaneous abortions. 
